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ABSTRACT 
 
Calcifying nanoparticles as novel etiologic agents of idiopathic preterm birth and 
preterm premature rupture of the membranes. Lydia L. Shook, Catalin S. Buhimschi, 
Antonette T. Dulay, Megan E. McCarthy, John T. Hardy, Christina M. Duzyj, Guomao 
Zhao, Irina A. Buhimschi. Department of Obstetrics, Gynecology and Reproductive 
Sciences, Yale University, School of Medicine, New Haven, CT. 
 
Preterm birth (PTB) is a leading cause of neonatal morbidity and mortality.  In many 
cases, preterm birth is preceded by preterm premature rupture of the membranes 
(PPROM) without any identifiable cause. Pathological calcification, i.e. the deposition of 
hydroxyapatite (HA) in non-skeletal tissue, has been implicated in degenerative diseases 
of soft tissue, such as atherosclerosis.  Multiple pathogenic mechanisms have been 
described, including the aberrant aggregation of HA into calcifying nanoparticles (CNPs) 
and the HA-induced differentiation of mesenchymal cells into osteoblasts in a process 
called ectopic osteogenesis.  The objective of this thesis was to explore the possibility 
that CNPs form in human amniotic fluid (AF), deposit in fetal membranes, and are 
mechanistically linked to pathogenic pathways leading to PPROM and PTB. In a cross 
sectional study of reproductive tissues collected from women with singleton preterm 
deliveries, we demonstrate that CNP deposition is more frequently observed in women 
with PTB and PPROM compared to intact membranes at clinical presentation.  
Immunohistochemical analysis revealed markers of ectopic osteogenesis in fetal 
membranes affected by HA deposition.  In a prospective study of AF from women 
presenting with preterm labor or PPROM who underwent amniocentesis to rule-out 
infection, we discovered decreased levels of fetuin-A, an endogenous inhibitor of 
biomineralization, as well as other essential AF proteins, in women with PPROM in the 
absence of infection.  In a long-term culture experiment, we observed aggregation of 
CNPs in the AF of women with PTB.  Furthermore, these AF-derived CNPs induced 
pathological structural and functional effects on term amniochorion explants.  In 
conclusion, the results of this thesis demonstrate that disruption of the protein-mineral 
balance of AF leads to CNP formation and deposition in fetal membranes, which may 
play a pathogenic role in PPROM and idiopathic preterm birth. 
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1. SPONTANEOUS PRETERM BIRTH. 
 
1.1 Definition and general trends. 
By the current definition, preterm birth is a delivery that occurs before 37 
completed weeks of gestation.  It affects nearly 12% of live births in the United States 
and remains the leading cause of perinatal morbidity and mortality in developing 
countries, with approximately 75-80% of perinatal deaths occurring preterm (1). The rate 
of preterm birth in the US has increased significantly over the past three decades, from 
9.5% in 1989 with a peak incidence of 12.8% in 2006 (2).  This concerning increase in 
the number of preterm birth is multifactorial and can be attributed to changes in 
obstetrical practice, neonatal medicine, and social and demographic factors such as 
advanced maternal age.  The increased use of assisted reproduction techniques and 
improved neonatal resuscitative capabilities are often cited as potential causes.  The 
ability to support the life of extremely preterm infants has led to a concomitant small rise 
in the number of births reported as preterm live births that would have previously been 
classified as stillbirths or spontaneous abortions (3).  
 Preterm birth is a heterogeneous entity that can be classified by the clinical 
circumstances in which it occurs: 1) delivery for medical indication, either maternal or 
fetal, by induction of labor or cesarean delivery; 2) spontaneous preterm birth preceded 
by preterm labor, defined as regular uterine contractions causing cervical change; or 3) 
spontaneous preterm birth preceded by preterm premature rupture of the membranes 
(PPROM), defined as spontaneous rupture of the membranes at least 1 hour before the 
onset of contractions.   
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Spontaneous preterm birth represents up to 65-75% of preterm births in the 
United States (2).  Furthermore, it continues to be extremely difficult to predict or prevent, 
despite our growing understanding of the underlying pathophysiology.  Spontaneous 
preterm birth is commonly subdivided into births preceded by preterm labor or by 
PPROM.   This distinction is clinically relevant because maternal risk factor profiles and 
underlying mechanisms for each condition differ.  Infection and inflammation, decidual 
hemorrhage, uterine over-distention, and maternal and fetal stress play key roles in the 
pathogenesis of preterm labor.   PPROM is likely the result of a convergence of similar 
mechanisms, but infection and inflammation may play a more important role in its 
pathogenesis.  Current understanding of the pathways of spontaneous preterm birth will 
be addressed in a subsequent section.   
 
1.2 Mortality and sequelae of prematurity. 
Preterm birth is the leading cause of perinatal mortality, and complications of 
prematurity account for greater than one-third of infant deaths.  At least 95% of deaths 
due to prematurity occur in infants born at less than 32 weeks, and two-thirds occur 
during the first 24 hours of life (4).  Perinatal mortality, defined as infant deaths under 7 
days of life and fetal deaths at 28 weeks of gestation or more, has been steadily declining 
in the past few decades; the most recent reported rate in 2006 was 6.51 deaths per 1000 
live births in the United States (NVSR 2006). Perinatal mortality rates are inversely 
related to gestational age, with the greatest risk of death occurring in extremely preterm 
neonates.  Furthermore, infant mortality is highly dependent on the level of neonatal care 
provided by the hospital (5).   
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Although improved neonatal care has resulted in an overall reduction in mortality 
associated with preterm birth, it has been paralleled by a rise in short-term morbidity and 
long-term physical and mental disability (6).  Compared to infants born at term, preterm 
infants have an increased risk of temperature instability, respiratory distress, 
hypoglycemia, seizures, jaundice, feeding difficulties, and rehospitalization (5).  Infants 
born extremely preterm (less than 28 weeks), particularly those born at the limit of 
viability, are susceptible to potentially devastating neurological and physical disability 
due to intraventricular hemorrhage, necrotizing enterocolitis, and bronchopulmonary 
dysplasia.  Neurodevelopmental sequelae include cerebral palsy, mental retardation, and 
visual and auditory deficits.  The rates of disability vary by report; one report estimates 
that approximately 20-25% of extremely preterm survivors have at least one major 
neurodevelopmental disability, and half of these disabled survivors have more than one 
disability (7).  Furthermore, extremely preterm infants that survive with normal 
intelligence and no cerebral palsy have an increased risk of developing gross and fine 
motor difficulties, impairment of visual processing and executive function, emotional 
control issues, and attention deficit disorder (1,5).  In addition, recent evidence suggests 
that the short- and long-term risks associated with late preterm and early term births have 
been underestimated (2,8,9).   
Since 2006, a modest but steady decline in preterm birth rates has been observed 
nationally.  The greatest reduction in preterm birth rates has occurred in the late preterm 
birth group, from 9.2% in 2006 to 8.5% in 2010, with a parallel decline in early term 
births (37-38 weeks) from 28.9% to 26.9% (1,2).  One explanation for this decline is 
changes in obstetrical practice: recognition of the slight increased risk of short- and long-
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term morbidity associated with late preterm and early term births may have precipitated a 
reduction in “elective” inductions and cesarean deliveries.  Growing recognition of the 
maternal risk and economic costs associated with elective cesarean delivery may also 
play a role.  
 
1.3 Economic impact. 
 In addition to its clinical sequelae, preterm birth is associated with a significant 
economic burden on families and the health care system.  It is estimated that in 2005, the 
annual societal economic costs associated with preterm birth in the United States was at 
least $26.2 billion (10,11).  The sources of economic cost include the cost of initial 
hospitalization, rehospitalization, continued care for physical and mental disability 
through childhood and adulthood, and lost family productivity.   
The reported cost associated with the initial hospitalization varies widely by 
region and time period studied and across gestational ages. Not surprisingly, a significant 
inverse relationship exists between gestational age and the costs associated with initial 
hospitalization (3,12).  The mean cost per survivor born at less than 28 weeks has been 
reported to range from approximately $100,000 to over $200,000 (13,14).  Preterm birth 
is also associated with significant costs in the first few years of life and throughout 
childhood.  Throughout childhood, the average cost to the public sector per survivor born 
at less than 28 weeks is more than three times the cost of a child born at term (9,15). 
Fewer data exist on the costs of prematurity throughout adulthood, although the 
persistence of disability and lost workplace productivity likely results in an additional 
economic burden to society (16,17). 
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1.4 Prevention of preterm birth. 
Single and multi-center epidemiological studies have identified multiple risk 
factors associated with spontaneous preterm birth (2,3).  Extremes of maternal age (18-
21), multiparity, poor nutritional status, and obesity are examples (18,22-24).  Adverse 
behaviors such as tobacco smoking, heavy alcohol consumption, and drug use (3,25) as 
well as socioeconomic disadvantage (22,26-28) have been repeatedly linked to adverse 
pregnancy outcomes.  High rates of preterm birth have been consistently observed in 
African Americans, independent of socioeconomic status and demographic 
characteristics. Finally, one of the strongest predictors of preterm birth is a history of 
spontaneous preterm birth in a prior pregnancy, conferring a 2.5-fold increased risk of 
preterm birth in subsequent pregnancies (7,29).   
The trend toward an increase in preterm birth rates over the past two decades has 
occurred despite primary and secondary interventions to reduce the known risk factors 
associated with preterm birth (30).  Unfortunately, predictive models that incorporate 
clinical characteristics and maternal risk factors have been met with limited success, 
likely due to the marked heterogeneity of the preterm birth syndrome (31).  Most success 
has instead occurred in the area of tertiary prevention once spontaneous preterm labor or 
PPROM has occurred, such as the use of antenatal corticosteroids to promote fetal lung 
maturity.  Women of racial minority groups and low socioeconomic status carry a 
disproportionately heavy share of the burden associated with preterm birth, an outcome 
that tends to recur in subsequent pregnancies.  Survivors of preterm birth often suffer 
from long-term disability, resulting in significant strain on families and substantial 
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economic costs to society.  For these reasons, preventing the occurrence and recurrence 
of preterm birth remains an important goal.  Understanding the causation of preterm birth 
is critical to achieving this endpoint.   
 
1.5 Common pathways to spontaneous preterm birth.  
Preterm birth is a clinical syndrome with many causes and phenotypes.  The 
classification of the preterm birth syndrome has been a topic of recent debate given its 
significant clinical heterogeneity and etiologic complexity.  Traditionally, it is thought 
that spontaneous preterm birth results from the early, “pathologic” activation of multiple 
pathways that are responsible for initiating normal term labor (3).  In this model, these 
pathways converge on a final common pathway, defined as the anatomic, biochemical, 
immunologic, endocrinologic, and clinical events that occur in the mother and fetus in 
both preterm and term labor (16).  The clinical events that signal the onset of spontaneous 
parturition at any gestational age, and thus the endpoints of the final common pathway, 
are: 1) myometrial contractions, 2) cervical shortening and dilatation, 3) fetal membrane 
rupture, and 4) bleeding.  
Figure 1 (next page) provides an illustration of the common pathways to preterm 
birth.  These include endocrine changes such as the activation of the maternal-fetal 
hypothalamic-pituitary-adrenal (HPA) axis, pathological myometrial stretch, decidual 
activation and bleeding, and infection and inflammation (32).  One explanation for the 
heterogeneity of the preterm birth phenotype is that there is substantial variation in the 
mechanisms underlying its pathogenesis. Preterm birth cases are described as idiopathic 
when no etiology can be identified.  
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Figure 1. Pathways to spontaneous preterm birth. 
PPROM = preterm premature rupture of the membranes. ??? = unknown etiology. 
 
 
 
 14	  
The final common pathway of both term and preterm labor involves endocrine 
changes such as increased corticotropin releasing hormone (CRH) and uterine 
progesterone withdrawal, enhanced myometrial contractility, and an inflammatory 
response marked by increased nuclear factor(NF)-κβ activity, cytokine production, and a 
leukocytic influx to reproductive tissues (16).  These changes lead to activation of 
myometrium contractility as well as structural remodeling of the cervix and fetal 
membranes by matrix metalloproteinases (MMPs), which are proteolytic enzymes that 
degrade collagen and other extracellular matrix components (33).   
While inflammation likely plays a “physiologic” role in the initiation of labor, 
independent of the presence of infection, it is important to note that bacterial infection 
can stimulate a pathological inflammatory response leading to preterm birth and fetal 
damage.  Indeed, the role of bacterial infection in the pathophysiology of preterm birth 
has been the focus of much investigation and will be discussed in a following section.   	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2. PRETERM PREMATURE RUPTURE OF THE MEMBRANES. 
 
2.1 Clinical significance of PPROM. 
Approximately one-third of spontaneous preterm births are preceded by preterm 
premature rupture of the membranes (PPROM), in which membrane rupture occurs prior 
to the onset of uterine contractions (29).  PPROM confers significant risk to the 
pregnancy because it is associated with a brief latency period from rupture to delivery, 
perinatal infection, and cord compression due to oligohydramnios (25).  Membrane 
rupture represents a breach of the sterile amniotic cavity and is often associated with 
chorioamnionitis and intra-amniotic infection (34,35).  Infection-associated preterm birth 
can be devastating to the neonate by the induction of a potentially damaging fetal 
inflammatory response, leading to neonatal outcomes that are worse than those predicted 
by the degree of prematurity alone (36-38).  
Risk factors that have been associated with PPROM include low socioeconomic 
status, African American race, maternal cigarette smoking, sexually transmitted 
infections, cervical conization, prior preterm labor in the current pregnancy, uterine 
distention, cervical cerclage, amniocentesis, and vaginal bleeding in the second or third 
trimesters (35).  Despite knowledge of these predisposing elements, it has proven difficult 
to either predict or prevent the occurrence of PPROM.  This is likely due to the fact that 
its etiology is multifactorial, and more than one pathophysiologic process may be evident 
in any given patient.   
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2.2 The pathophysiology of fetal membrane rupture. 
In normal human gestation, the fetal membranes function to: 1) maintain a barrier 
to ascending bacterial infection, 2) expand to accommodate the growing fetus, 3) resist 
the gravitational and mechanical forces of fetal activity, and 4) rupture at the time of 
delivery.  The fetal membranes are therefore in dynamic equilibrium between growth, 
stretch, repair, and degradation throughout pregnancy.  Structurally, the membranes 
consist of the amnion and choriodecidua, which are both viscoelastic and avascular.  The 
amnion epithelium is the innermost layer and communicates directly with the amniotic 
fluid.  It is supported by the basement membrane and the compact layer, composed 
primarily of type I and III fibrillar collagen (39). Fibroblasts of the compact layer actively 
maintain the extracellular matrix, which consists of collagen, proteoglycans (e.g. biglycan 
and decorin), and a small amount of fine elastin.  Mechanically, these components 
provide tensile strength, cushioning, and elasticity.  The chorion contains 
cytotrophoblasts embedded in types IV and V collagen and is closely applied to the 
maternal decidua (40). 
Mechanical stretch and distention, enzymatic degradation of the extracellular 
matrix, and cellular apoptosis are key pathways to membrane rupture, at term and 
preterm gestational ages.  Mechanical stretch plays a role in membrane weakening in two 
ways: 1) acute cyclic stretch, such as that which occurs with Braxton-Hicks contractions, 
induces complex changes in the physical properties of membranes resulting in non-
recoverable deformation (41); and 2) chronic mechanical stretch applied to fetal 
membranes increases the expression of factors involved in degradation of the 
extracellular matrix (42).  In pregnancies complicated by pathological distention, such as 
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multiple gestation or polyhydramnios, mechanical stretch of the fetal membranes likely 
plays a significant role in the etiology of membrane rupture. 
In addition to physical stress and deformation of the membranes, MMP-mediated 
degradation of the extracellular matrix has been implicated in term membrane rupture as 
well as the in the pathophysiology of PPROM.  MMPs are zinc-dependent proteolytic 
enzymes that have specificities for different collagen types and other glycoprotein 
components of the extracellular matrix in the amniochorion.  The disruption of the 
balance between MMPs and their inhibitors, the tissue inhibitors of matrix 
metalloproteinases (TIMPs), leads to catabolism of the extracellular matrix, disrupting its 
structural integrity.  Degradation of collagen and other proteoglycans also exposes active 
domains of factors involved in cell signaling (43).  Many MMPs have been described in 
the amniochorion, but data from human and animal studies suggest that gelatinases 
MMP-2 and MMP-9 are directly involved in the pathogenesis of PPROM in both the 
presence and absence of infection (43,44). 
Activation of apoptotic cell death pathways has been described at membrane 
rupture sites in human tissues and across the entire membrane surface in animal models 
(43).  Activators of these pathways, such as TNFα, Fas ligand, and lactosylceramides, 
which have been demonstrated in amniotic fluid, drive apoptosis in amnion epithelial 
cells and fibroblasts in vitro (45,46).  Furthermore, levels of mRNA and protein 
expression of apoptotic elements are elevated in the amniotic fluid and fetal membranes 
of PPROM cases compared to spontaneous preterm labor controls (47).  Experimental 
evidence suggests that MMP activation and apoptosis are interrelated: the basement 
membrane and extracellular matrix are major stabilizing factors that support the 
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differentiated phenotype of cells, and their breakdown by MMPs can lead to the 
activation of apoptotic pathways (46).  The release of apoptotic signals, in turn, can 
activate Toll-like receptors (TLRs) that induce MMP expression and extracellular matrix 
catabolism in a feed-forward fashion (40).  Interestingly, an increase in PGE2 release 
parallels the induction of apoptosis in amnion epithelial and mesenchymal cells in vitro, 
and PGE2 is known to induce and activate MMP-9 in cultured amniochorion tissue 
(45,48).   
The net result of these interconnected and synergistic pathways is a local 
weakening of the fetal membranes leading to membrane rupture.  Meticulous studies 
mapping the histological changes at multiple locations of the fetal membrane surface 
have demonstrated that these changes are heterogeneous across the surface of the 
membranes, and occur in both PPROM and term membrane rupture (49,50).  Rupture 
occurs at a “zone of extremely altered morphology” that overlies the cervix, which is 
characterized by marked swelling and disruption of the connective tissue, trophoblast 
apoptosis, and thinning of the maternal decidua (40,51).  Observations at the rupture site 
include a loss of lattice-like organization of collagen, alterations in MMP and TIMP 
levels, and histological features consistent with cellular apoptosis (40).  
 
2.3 Infection, inflammation, and oxidative stress: proposed mechanisms of PPROM. 
As previously discussed, there is significant overlap in the mechanisms 
responsible for the initiation of uterine contractions, cervical change, and membrane 
rupture.  However, certain pathways appear to play a more prominent role in preterm 
birth cases clinically characterized by PPROM, potentially including MMP-mediated 
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degradation of the extracellular matrix and apoptosis.  Furthermore, the pathways leading 
to membrane rupture in PPROM are possibly triggered by different etiologic agents than 
those driving membrane rupture at term.   
There is substantial clinical and experimental evidence pointing to the importance 
of infection-induced acute inflammation in the pathophysiology of PPROM (46).   It has 
been reported that clinically evident intra-amniotic infection occurs in up to 60% of 
PPROM cases, with the incidence of infection increasing with decreasing gestational age 
at the time of rupture (52). The current paradigm for intra-amniotic infection is that lower 
genital tract bacteria gain access to the amniotic cavity by an ascending mechanism in 
which they overcome host defenses in the cervix and sequentially invade the maternal 
decidua, fetal membranes, and amniotic cavity, inducing an inflammatory response (53).   
However, degradation of the fetal membranes by inflammatory pathways is not 
always associated with bacterial infection.  PPROM in the setting of placental abruption 
is associated with a marked decidual infiltrate of neutrophils, which are a source of 
proteases, elastases, and MMPs, and this occurs in both the presence and absence of 
infection (54).  Furthermore, damage associated molecular pattern molecules (DAMPs), 
which are a group of endogenous molecules associated with cellular damage, can 
stimulate an acute and chronic inflammatory response through the activation of TLRs and 
the Receptor for Advanced Glycation End-Products (RAGE) (55,56).  DAMPs are 
associated with a late-stage response to infection as well as a chronic inflammatory state 
not necessarily infectious in origin.  
Oxidative stress also appears to be an important predisposing factor for membrane 
rupture.  A reduction in the activity of the protective antioxidants glutathione peroxidase 
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and superoxide dismutase has been demonstrated locally in fetal membranes overlying 
the cervix.  In vitro data suggest that MMP-9 activity is increased by the superoxide 
anion, a reactive oxygen species that is produced by macrophages and neutrophils present 
in abundance in PPROM cases complicated by infection and decidual bleeding (57-59).  
The observed association between maternal cigarette smoking and PPROM may be the 
result of increased oxidative stress: when exposed to cigarette smoke extract in vitro, fetal 
membranes expressed increased levels of F2-isoprostane, a biomarker of oxidative stress, 
as well as markers of apoptosis and DNA fragmentation (60).   
It is important to note that infection can be both a cause and consequence of fetal 
membrane weakening.  Prior to the point of gross rupture, loss of fetal membrane 
integrity can lead to increased susceptibility to bacterial infection through disruption of 
natural host defenses.  At the time of clinical presentation, it is often difficult to 
determine whether infection precedes or follows membrane rupture, particularly if 
significant delay occurs between rupture and presentation for evaluation.  Although 
infection clearly plays an important causal role, it is likely that other factors contribute to 
compromising the integrity of the fetal membranes and reducing resistance to ascending 
infection.  In most cases, the etiology of PPROM is multifactorial.   
 
2.4 Idiopathic PPROM and preterm birth. 
 Idiopathic preterm birth refers to spontaneous preterm birth preceded by either 
PPROM or preterm labor in which no direct etiology, such as intra-amniotic infection or 
placental abruption, can be determined.  The reported incidence of infection in cases of 
spontaneous preterm birth varies widely in the literature.  Depending on the sensitivity of 
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the test used or the patient population studied, evidence of bacterial infection is reported 
in 15-72% of spontaneous preterm birth cases (34).   
Recent advances in detection methods are partially responsible for the increase in 
the reported rates of infection.  For example, the experimental use of PCR sequencing of 
16S ribosomal RNA to detect bacterial signatures in amniotic fluid has revealed the 
presence of bacteria that resist cultivation by conventional methods (61). However, the 
clinical significance of microbes identified in the amniotic fluid is not always apparent: 
some strains of bacteria identified in amniotic fluid exhibit low virulence in culture and 
thus may not be pathogenic (62).  Using proteomic analysis of the amniotic fluid, 
Buhimschi et al. demonstrated unique biomarker patterns indicative of inflammatory 
responses that correlate with poor neonatal outcomes, thereby providing a method of 
detecting clinically significant intra-amniotic infection (63).  Despite the increased 
sensitivity and specificity of this method, the cause of many preterm birth cases remains 
unknown. 
Recent attempts to uncover the etiology of idiopathic preterm birth cases have 
been met with limited success.   Proteomic profiling of the amniotic fluid of women with 
idiopathic preterm birth identified an abnormal, non-inflammatory protein profile in a 
subgroup of women at an increased risk of preterm birth (64).  Histological markers of 
placental insufficiency have also been demonstrated in some cases of idiopathic preterm 
birth (65).  The search for novel etiologic mechanisms of idiopathic preterm birth remains 
an important task.   
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3. A ROLE FOR CALCIFYING NANOPARTICLES IN IDIOPATHIC 
PRETERM BIRTH.  
 
3.1 “Nanobacteria” and diseases of ectopic calcification. 
Calcifying nanoparticles (CNPs) are mineral-protein complexes involved in the 
development of pathological calcification (66-68).  When first identified in human blood, 
these 50-500 nm structures were given the name “nanobacteria” due to their similarities 
to infectious agents: they appeared to multiply in culture and exert cytotoxic effects in 
vitro and in vivo (69,70).  Following this discovery, further investigations into the identity 
of nanobacteria led to controversy over their classification as living matter (71).  Their 
small size, resistance to sterilization, and inconclusive evidence for genetic material 
prompted scientists to revise the name of nanobacteria to the less audacious term 
“calcifying nanoparticles” (72). 
While their infectious capabilities have been essentially disproven, their role in 
disease pathogenesis remains an open question.  Since their initial description, CNPs 
have been implicated in many diseases of ectopic calcification, defined as the 
pathological deposition of hydroxyapatite (calcium phosphate) in non-skeletal tissue (73).  
These conditions include nephrolithiasis (70,74), atherosclerotic plaques (75,76), arthritis 
(77,78), ovarian cancer (79), and aortic valve calcification (80).     
The role of CNPs and CNP-mediated ectopic calcification in disorders of 
pregnancy has received little attention.  Calcified plaques are often seen on pathological 
examination of the placenta, yet the clinical significance of placental calcification is 
controversial.  At term, placental calcification is a common finding and is not considered 
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pathological.  Reports are conflicting regarding the significance of preterm placental 
calcification in low-risk populations.  In high-risk pregnancies, the presence of preterm 
placental calcification by ultrasound appears to predicts poor uteroplacental blood flow 
and adverse pregnancy outcomes, particularly if calcification is noted prior to 32 weeks 
(81).  However, the causal relationship between calcification and preterm birth is not well 
understood.  To our knowledge, calcification of fetal membranes has never been 
described in the literature. 
One observational study has demonstrated the existence of a “nanobacteria-like 
infection” in placental tissues obtained from women with pathological placental 
calcification identified by ultrasonography, but the sample size was small (82).  A recent 
case study of placental calcification described similar nanobacteria-like particles in the 
basement membrane and syncytio-trophoblast cytoplasm of placental villi (83).  However, 
the mechanistic link of these “nanobacteria-like” deposits to disorders of pregnancy is 
unknown.  
 
3.2 Process of formation and mechanisms of CNP pathogenicity 
Recent studies have provided important insights into the process of CNP 
formation in biological systems, illustrated in Figure 2 (next page) (67,68). In biological 
solutions, calcium and phosphate have a tendency to form hydroxyapatite (HA), a 
crystalline compound composed primarily of calcium and phosphate.  HA formation is 
controlled by the plasma protein fetuin-A, an endogenous inhibitor of calcification 
produced by the liver (84,85).  Fetuin-A is highly attracted to nascent HA, and once 
bound, it inhibits further crystallization.  Fetuin-A thus allows normally insoluble mineral 
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to exist in a stable, colloidal form (86).  However, when fetuin-A binding sites are fully 
saturated, the fetuin-HA complex becomes a nidus for further mineralization, resulting in 
the formation of poorly crystalline, macromolecular complexes (67).  These intermediates 
have the potential to aggregate into larger, pleomorphic structures that become insoluble 
and precipitate out of solution, resulting in tissue mineralization.  During the process of 
aggregation, CNPs attract and bind other soluble proteins (87). 
 
Figure 2. Process of CNP formation. A two-step process: (A) fetuin-A binds nascent 
hydroxyapatite (HA) forming colloidal macromolecular intermediates (B); (C) 
aggregation of intermediates into mature, insoluble CNPs, which trap other proteins in 
the process of their assembly. 
 
Multiple ontological frameworks have been used to understand the pathogenicity 
of CNPs.  CNPs were initially considered the smallest living pathogen, similar to bacteria 
or viruses.  Early investigation centered on their ability to be isolated from human fluids 
and induce known inflammatory pathways in multiple cell and tissue types in vitro.   
Macrophage internalization of CNPs induces TNF-alpha production through multiple 
inflammatory signaling pathways(88).  CNPs also stimulate inflammatory responses 
through TLR-mediated extracellular signaling pathways in both immune and non-
immune cells (88-90).   
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Further investigation has demonstrated that CNPs induce a variety of non-
inflammatory effects as well. CNP internalization by vascular smooth muscle cells 
induces apoptosis and eventual cell death (91).  Studies in vivo and in vitro have shown 
that CNPs initiate apoptosis of renal epithelial cells by inducing oxidative stress and 
membrane lipid peroxidation (92).  Their degree of toxicity depends on the size of 
individual units: small, colloidal CNPs tend to exhibit greater pro-apoptotic effects over 
their larger insoluble counterparts (91-93).  These results suggest that as pathogens, CNPs 
exert pleiotropic effects. 
 
3.3 Ectopic calcification and pathologic osteogenesis. 
Another framework that has been used to understand the pathogenicity of CNPs 
draws on their structural and functional similarities to lipoproteins.  Similar to 
hydroxyapatite, lipids are insoluble in biological fluids, and the body has developed a 
system of protein chaperones (apolipoproteins) that enable its transport and clearance.  
Analogous to apolipoproteins, fetuin-A is one of several circulating proteins that binds 
hydroxyapatite, forming soluble macromolecular particles that are transported to the liver 
and kidneys and cleared, thus preventing excess mineralization (94).  The pathogenicity 
of CNPs can be considered in the context of a redundant system of checks and balances 
that regulates mineral homeostasis.  Any disruption to this system can lead to the aberrant 
propagation and deposition of mineral products in soft tissue, resulting in the downstream 
effects of inflammation, apoptosis, and extracellular matrix degradation, thus leading to 
compromised tissue structure and function.  
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Interestingly, the link between lipoproteins and CNPs extends beyond their 
conceptual similarities: both entities play key roles in the pathogenesis of atherosclerosis. 
Studies of vascular tissue, in turn, have provided important insight into the mechanisms 
involved in ectopic calcification of all soft tissues.   Key events in the development of 
calcified atherosclerotic plaques include 1) alteration in the phenotype of vascular smooth 
muscle cells known as trans-differentiation, 2) elaboration of bone morphogenic proteins 
and 3) degradation of extracellular matrix components, particularly elastin (95,96).  In a 
process termed ectopic osteogenesis, normally contractile vascular smooth muscle cells 
differentiate into a proliferative, osteoblastic phenotype.  These cells have dramatically 
altered gene expression profiles and produce proteins involved in CNP nucleation and 
skeletal matrix synthesis (97).  Expression of the transcription factors RUNX2 and 
Osterix is essential to committing the cell to the osteoblastic lineage (98,99).  Protein 
markers of mature osteoblastic function have also been demonstrated in advanced 
atherosclerotic lesions (100).  These proteins-- osteocalcin, osteopontin, and osteonectin-- 
are non-collagenous proteins present in the organic component of bone matrix.  
Osteocalcin is the most abundant of these proteins and is only produced by mature, non-
proliferating osteoblasts (101).  	  
Various stimuli can induce osteogenic differentiation of multipotent progenitor 
cells of vascular smooth muscle cells in vitro.  Cellular contact with HA is a potent 
stimulus for osteogenic differentiation (102-105).  Inflammatory cytokines such as IL-6 
and TNF as well as oxidative stress have also been implicated in osteogenic 
differentiation (95,106,107). In vascular models, loss of cyclic stretch forces, such as 
those associated with normal arterial blood flow, induces the phenotypic switching of 
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smooth muscle cells to osteoblast-like cells (108).  The functional effect of osteoblastic 
differentiation is significant: not only do osteoblasts deposit HA aberrantly, but 
reprogrammed fibroblasts or smooth muscle cells cannot perform their normal functions.  
Connective tissues affected by osteogenic differentiation and ectopic calcification thus 
lose their natural visco-elasticity and are prone to rupture.	  
Prior work in the field of tissue engineering has demonstrated that indigenous 
cells of the fetal membranes are capable of induced differentiation down multiple cell 
lines in vitro (109).  In the presence of culture media containing hydroxyapatite, these 
cells are capable of differentiating into an osteoblast-like phenotype in which they 
develop the necessary machinery for nucleating additional hydroxyapatite (110). 
However, the differentiation of amniochorion cells into osteoblasts has never been 
described in vivo.  	  	  
3.4 CNP formation and related pathology: an unrecognized analogy to amyloid? 
The link between CNPs and protein conformational disorders has neither been 
formally proposed nor described prior to our investigation.  This section will highlight 
some of the conceptual similarities between these two disease processes in the hope that a 
new framework might be used to further shed light on the pathogenic role of CNPs. 
“Amyloid” is a general term for peptide aggregates that share certain features 
such as a fibrillar morphology, β-pleated sheet structure, birefringence upon staining with 
the dye Congo Red, insolubility to detergents, and protease resistance (111).  The most 
well-studied disease of protein aggregation is Alzheimer’s disease, in which a cleavage 
product (Aβ) of the amyloid precursor protein misfolds and aggregates into plaques.  
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Other peptides with the propensity toward amyloid formation are α-synuclein and the 
huntingtin protein, involved in Parkinson’s disease and Huntington’s disease, 
respectively (111). It is now recognized that heterogeneous aggregates can be formed 
from the association of multiple peptides (112), though this area is only beginning to be 
explored. 
Mechanisms of amyloid formation are complex and variations exist between 
disease models studied.  However, common features include: 1) an initial step of protein 
misfolding or denaturation; 2) the acquisition of the ability to form self-propagating 
aggregates; 3) the formation of intermediate, partially-stable oligomers; and 4) a final 
step of conformational change or annealing process in which soluble oligomers form 
stable amyloid fibrils (113).  The kinetics of aggregation are dependent on temperature, 
pH, and initial protein concentration, which vary by peptide (114).  Common structural 
motifs of these proteins include cross-linking of β-sheets, but initial polypeptide 
sequences vary immensely (111). 
A growing body of evidence suggests that the intermediate oligomers produced 
during amyloid formation are primarily responsible for amyloid pathogenesis, rather than 
mature amyloid fibrils themselves (115).  The general consensus is that the primary 
mechanism of pathogenesis common to all amyloid oligomers is the permeabilization of 
cell membranes (115).  Damage to the membrane’s lipid bilayer results in ionic influx, 
release of intracellular calcium stores, disregulated transmembrane signaling, production 
of reactive oxygen species, and, ultimately, apoptosis or autophagy (113,116). 
Disorders of protein aggregation are a hot field of investigation.  Many age-related 
degenerative diseases are associated with accumulation of amyloid plaques, and the list is 
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growing rapidly.  Type 2 diabetes and multiple myeloma are thought to involve 
accumulation of misfolded protein aggregates, and most recently, Buhimschi et al. have 
proposed the novel idea that preeclampsia is itself a protein conformational disorder 
(117).
Historically, CNPs have been thought of as infectious agents, as their original 
moniker “nanobacteria” suggests.  However, CNPs and amyloid have many 
characteristics in common.  As previously outlined, CNPs are mineral-protein aggregates 
that are resistant to detergents and proteases, and their propensity to form is highly 
dependent on the physicochemical properties of their environment such as temperature 
and pH.  Also similar to amyloid, CNPs have been implicated in degenerative processes 
associated with aging tissues, such as atherosclerosis.  Furthermore, amyloid plaques 
have the tendency to calcify in vivo (118-121). In the results section of this thesis, we will 
present evidence that link CNPs to amyloid and propose that their pathogenic effects may 
be more akin to protein conformational disorders than infectious diseases. 
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4. STATEMENT OF PURPOSE 
 
The hypothesis at the basis of the research presented in this thesis is that CNPs form in 
the amniotic cavity, deposit in fetal membranes, and are involved in pathogenic pathways 
leading to membrane rupture and spontaneous preterm birth.  If this hypothesis holds true, 
identifying markers of CNP formation in the amniotic fluid of women with signs or 
symptoms of preterm birth may have significant prognostic value.  Furthermore, a 
detailed knowledge of the pathways by which CNPs affect reproductive tissues, including 
the potential for inducing ectopic osteogenesis, may provide areas for targeted therapeutic 
intervention.  We therefore propose to investigate the presence of CNPs in reproductive 
tissues with the goal of determining the mechanisms by which CNP aggregation 
contributes to the pathogenesis of preterm birth.   
 
4.1 Specific Aim 1: To investigate the presence of CNPs and/or ectopic osteogenesis in 
the reproductive tissues of women with pregnancies complicated by spontaneous 
preterm birth. 
To achieve this aim our objectives were as follows:  
a) To investigate the presence of HA using histochemical stains for calcium 
phosphate in placental and amniochorion tissues from preterm women and non-
laboring term controls. 
b) To determine the co-localization of HA and fetuin-A, a HA-binding protein and 
known component of CNPs, in serial sections of representative samples. 
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c) To determine the relationship between the degrees of HA amniochorion 
deposition in women with spontaneous preterm birth in the presence or absence of 
histological chorioamnionitis (HCA) and PPROM and in non-laboring term 
controls. 
d) To determine whether fetuin-A is present in the AF of women with preterm birth 
and to compare its levels to gestational age matched controls. 
e) To determine the levels of fetuin-A, free ionized calcium, and inorganic 
phosphate in the AF of preterm women in the presence or absence IAI and 
PPROM.   
f) To compare AF levels of CNP-related proteins (fetuin-A and albumin) and 
proteins produced by the amniochorion with potential involvement in PPROM 
(IL-6 and MMP-9) in patients with idiopathic preterm birth. 
g) To investigate the presence of markers of osteogenic differentiation (osteocalcin, 
RUNX2, osterix, osteonectin, osteopontin, and alkaline phosphatase) in the 
amniochorion of preterm (idiopathic) and term women. 
h) To identify amniochorion cells with stem cell pluripotency by investigating the 
presence of stem cell/reprogramming transcription factors (Oct4, SOX2, Nanog 
CDX2) in fetal membranes. 
i) To investigate the mRNA expression of fetuin-A and markers of osteogenic 
differentiation (osteocalcin, RUNX2, and alkaline phosphatase) in representative 
amniochorion samples. 
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4.2 Specific Aim 2: To experimentally determine the capability of human AF to 
generate CNP aggregates. 
To achieve this aim in an in vitro experimental study design, our objectives were as 
follows: 
a) To generate CNPs in a long-term AF culture system. 
b) To examine the structure and composition of AF-derived CNPs by light 
microscopy and electron and immuno-electron microscopy for known CNP 
components (fetuin-A, albumin) and an endogenous AF protein (IL-6). 
c) To investigate the effect of CNP formation on the biochemical composition of AF 
by measuring the concentrations of calcium, phosphate, and glucose by 
biochemical assays in AF before and after CNP formation. 
d) To investigate the effect of CNP formation on the protein composition of AF 
using ELISA to measure the concentrations of fetuin-A, albumin, and IL-6 before 
and after CNP formation. 
 
4.3 Specific Aim 3: To identify the pathways by which CNPs and/or ectopic 
osteogenesis may lead to membrane rupture and idiopathic preterm birth. 
To achieve this aim in an ex vivo experimental study design, our objectives were as 
follows: 
a) To investigate the effect of AF-derived CNPs, exogenous HA nanoparticles, and 
native AF on the structure and function of amniochorion from non-laboring term 
women. 
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b) To examine the pattern of glucose consumption and PGE2, MMP-9 and IL-6 
release by amniochorion in response to CNP challenge. 
c) To determine the effect of CNP challenge on the collagenous extracellular matrix 
of amniochorion. 
d) To determine the effect of CNP challenge on cellular apoptosis of amniochorion 
cells. 
e) To determine the effect of CNP challenge on the osteogenic differentiation of 
amniochorion stem cells. 
f) To determine the mechanism of CNP cytotoxicity by measuring their ability to 
induce lysis of red blood cells in vitro. 
g) To determine the amyloidogenic potential of CNPs by determining their ability to 
bind the dye Congo Red. 
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5. PATIENTS AND METHODS 
5.1 Patient population and biological samples.  
A flowchart of the women enrolled in the study outlining the subgroups of 
analyzed samples is presented in Figure 3 (next page). All experimental procedures and 
data analyses were performed by the author unless otherwise specified. 
Amniotic fluid was retrieved from 176 consecutive women who had a clinically 
indicated amniocentesis at Yale-New-Haven-Hospital from March 2004 to December 
2008 by the clinical team.  All women provided informed consent and the study was 
approved by the Human Investigational Committee of Yale University.  
We studied the following clinical groups: i) second trimester women undergoing genetic 
amniocentesis who delivered a healthy baby at term [gestational age (GA) median 
[interquartile range (IQR)]: 18 [17-20] weeks, n=40); ii) third trimester women 
undergoing fetal lung maturity testing prior to delivery (GA: 36 [36-37] weeks, n=37) 
and iii) women presenting with preterm labor or PPROM who had an amniocentesis to 
rule-out infection (GA: 29 [25-31] weeks, n=126). This last group was further divided 
into: women with negative IAI and intact membranes (GA: 28 [24-31] weeks, n=47), 
women with negative IAI and PPROM (GA:  30 [29-31] weeks, n=27), women with 
positive IAI and intact membranes (GA: 25 [24-28] weeks, n=26) and women with 
positive IAI and PPROM (GA:  29 [26-31] weeks, n=26). Of the 47 cases with negative 
IAI and intact membranes, 22 women delivered a healthy term baby.  Clinical 
characteristics of these patients are provided in Table I. 
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Figure 3. Flowchart of women and biological samples used in this study.   
IAI = intra-amniotic inflammation. ROM = rupture of membranes. HCA = histological 
chorioamnionitis.  CRL = control. ELISA = enzyme-linked immunosorbent assay. Neg = 
negative. Pos = positive.  *This scheme does not include AF samples obtained for in vitro 
incubations of CNPs, which were used fresh following amniocentesis. 
 
These cases were analyzed along with second and third trimester control groups to 
identify possible GA mediated changes. A cut-off of 27 completed weeks GA was chosen 
to delineate the second (<28 wks GA) from third trimester (≥28 wks GA). The 
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indications for the second trimester amniocentesis included: advanced maternal age, 
personal preference for testing, abnormal serum screening, or presence of minor 
ultrasound markers suggestive of aneuploidy (choroid plexus cyst, intra-cardiac 
echogenic foci). Amniocentesis results for all women included in this group showed 
normal fetal karyotypes. The third trimester group consisted of healthy women where 
confirmation of fetal lung maturity was clinically indicated prior to induction of labor or 
surgical delivery (Cesarean Section).  Clinical characteristics of these patients are 
provided in Table II. 
Preterm labor was defined as the presence of regular uterine contractions and 
documented cervical effacement and/or dilatation in patients <37 wks GA. Preterm birth 
was defined as delivery of the fetus <37 wks GA. Preterm premature rupture of 
membranes was confirmed by visualization of vaginal “pooling” at sterile speculum 
examination, and positive “nitrazine” or “ferning” tests. When necessary an intra-
amniotic “dye test” (infusion of indigo carmine) was used (n=25). Exclusion criteria for 
the study population included: chromosomal aneuploidy, fetal structural abnormalities, 
intrauterine growth restriction, multiple gestation, uterine contractions for the 2nd and 
3rd trimester controls, known maternal medical conditions, anhydramnios, viral infection 
(human immunodeficiency or hepatitis), and fetal heart rate abnormalities at enrollment 
(i.e. bradycardia, prolonged/repeated variable decelerations) requiring emergent delivery. 
Placental villous and amniochorion tissue samples were provided by 109 women 
with spontaneous preterm delivery who had provided prior AF samples and 18 women 
with elective term Cesarean Section.  The women in the former group were selected for 
study without bias to risk factors for spontaneous preterm birth, and the women in the 
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latter group (GA: 38-40 weeks) consisted of healthy, term, non-laboring women, 
undergoing a scheduled elective Cesarean delivery for indications such as fetal 
malpresentation (i.e breech) or prior Cesarean delivery. All of their infants were 
appropriately grown for GA and had reassuring fetal heart rate patterns prior to surgery.  
Selection of samples from the biological repository for the purpose of the analyses 
included herein was based on clinical diagnoses at sample collection and/or outcome and 
was done not by me and prior to my evaluation of analytes of interest or statistical 
analysis.  None of the originally selected samples was excluded from the final analysis.  
All clinical data was extracted from patient charts by one investigator (IAB). 
 
5.2 Protocol implemented for the clinical care of the preterm labor patients. 
Management of the patients was left to the clinical team. Based on the American 
Congress of Obstetrics and Gynecology recommendations, PPROM was managed 
expectantly in the absence of clinical laboratory results suggestive of infection, or 
signs/symptoms of clinical chorioamnionitis (fever >100.40F, abdominal tenderness, fetal 
tachycardia), and/or abnormalities of fetal heart rate (variable or late decelerations), 
and/or abruption. If PPROM occurred, digital exams were not allowed.  Patients received 
corticosteroids for lung maturity if ≤32 weeks GA and antibiotic therapy as clinically 
indicated. The vast majority of preterm labor/PPROM women (80%) had their 
amniocentesis procedure performed prior to antibiotic or steroid therapy. Inpatient 
women were monitored by cardiotocography at least twice daily for the presence of fetal 
heart abnormalities and/or uterine contractions. 
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The decision for amniocentesis, expectant management, tocolysis or indicated 
delivery was made by the primary physician independent of our research protocol. The 
clinical management team was not aware of our research test results. Following 
amniocentesis, each woman was followed prospectively to delivery. Indicated delivery 
through induction of labor or Cesarean section was performed for such clinical 
indications as AF laboratory results traditionally considered to indicate IAI/infection, 
fetal lung maturity, prolapsed umbilical cord and/or GA ≥34 weeks.   
 
5.3 Laboratory studies of AF and reproductive tissue samples. 
Amniotic fluid was analyzed for glucose concentration, lactate dehydrogenase 
activity, white blood cell count and Gram stain. Standard culturing methods for aerobic 
and anaerobic bacteria, including Ureaplasma and Mycoplasma species were employed. 
Positive Gram stain and/or culture results were considered suggestive of intra-amniotic 
infection. The results for these studies were used for clinical case management of the 
cases.  Once the clinical requirements were satisfied, the remaining AF was centrifuged 
at 3000g and 4ºC for 10 min., aliquoted, and stored at -80ºC for research purposes.  All 
analysis was performed during the course of clinical management by the Laboratory staff 
at Yale-New Haven Hospital. 
Evaluation of the presence of IAI. In previous studies, our group demonstrated 
that proteomic profiling of AF using surface-enhanced laser-desorption ionization time of 
flight (SELDI-TOF) mass spectrometry was the most accurate research method for 
diagnosing IAI (63). The MR score is comprised of 4 proteomic biomarkers: defensin-2, 
defensin-1, S100A12 (calgranulin C) and S100A8 (calgranulin A), and scores range from 
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0 to 4 depending upon the presence or absence of each of the 4 protein biomarkers. All 
mass spectrometry tracings were scored by one investigator (IAB) who was unaware of 
the results of the biochemical or microbiological tests used to diagnose IAI clinically.  
For the purpose of this study, we used an MR score of 3 or 4 alone to indicate the 
presence of IAI. 
Evaluation of histological chorioamnionitis.  Histological evaluation of the 
placenta and amniochorion is routinely performed for all preterm birth cases at Yale-New 
Haven Hospital by staff affiliated with the Department of Pathology.  Placental and fetal 
membrane tissue biopsies were collected immediately after delivery, fixed in formalin, 
and embedded in paraffin.  For clinical purposes, a diagnosis of histological inflammation 
of the placenta and fetal membranes was based on well-established criteria (122).   
 
5.4 Histological and immunohistological procedures. 
Histochemical staining for hydroxyapatite (HA) deposition was performed on 5-
µm deparaffinized rehydrated tissue sections.  To establish the presence of calcium and 
phosphate in these tissues, the von Kossa method for phosphate and the Alizarin S 
method for calcium were performed using standard protocols.  A qualitative analysis of 
the location and pattern of HA deposition in the amnion, chorio-decidua, and placental 
villous tissues was performed.  The extent of HA deposition was evaluated semi-
quantitatively by scoring the density of deposits on a graded scale of 0 (no staining) to 2 
(heavy staining).  Histological scoring occurred in a blinded fashion whenever possible. 
Immunohistochemistry for fetuin-A was performed in select tissues with positive 
(n=11) and negative (n=8) HA staining.  Paraffin tissue sections (5µm) were 
 40	  
deparaffinized in xylene and rehydrated with graded ethanol to potassium-phosphate-
buffered saline solution, pH 7.2. Following antigen retrieval with citrate buffer (pH=6), 
the sections were pretreated with 1.5% hydrogen peroxide for 15 min. followed by 1 hour 
blocking with 5% donkey serum.  Goat anti-human fetuin-A primary antibody was used 
(Novus Biologicals, Littleton, CO, 1:10000, overnight incubation at 4°C).  Following 1-
hour incubation with biotinylated donkey anti-goat secondary antibody (1:600 dilution, 
Novus Biologicals), the sections were developed using the avidin-biotin-peroxidase 
system (Vectastain Elite ABC, Vector Laboratories, Burlingame, CA) with Vector 
NovaRed (Vector Laboratories) as chromogen and hematoxylin as counterstain. The 
tissue sections were dehydrated in graded ethanol, cleared, and mounted. Specificity of 
staining was confirmed by replacing the primary antibodies with equivalent 
concentrations of goat non-immune IgG (Novus Biologicals).  The location and pattern of 
fetuin-A deposition was described by qualitative analysis. The relationship of fetuin-A to 
HA deposition was characterized by performing von Kossa, Alizarin S, and fetuin-A 
immunohistochemistry procedures in serial sections of placental and amniochorion 
tissues (n=11). 
Immunohistochemistry for markers of osteogenic differentiation was performed in 
select amniochorion samples with positive (n=17) and negative (n=9) HA staining in the 
absence of histological chorioamnionitis.  The same protocol was followed as outlined 
above with appropriate modifications.  Primary antibodies for the following proteins were 
selected as follows: osteocalcin, a marker of mature osteoblasts (mouse monoclonal, 
1:100, R&D systems); 2) transcription factors RUNX2 (mouse monoclonal, 1:200, 
Abcam) and osterix (rabbit polyclonal, 1:500, Abcam) ; and 3) non-bone specific markers 
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of osteoblast activity including osteonectin (mouse monoclonal, 1:100, R&D), 
osteopontin (mouse monoclonal, 1:100, R&D) and alkaline phosphatase (mouse 
monoclonal, 1:100, US Biological, Swampscott, MA) (98,101,123,124).  Transcription 
factors SOX2 (rabbit anti-human polyclonal, 1:1000, Novus), CDX2 (rabbit anti-human 
monoclonal, 1:500, Novus), and Nanog (rabbit polyclonal, 1:100, Novus) were also 
analyzed as indicators of cell pluripotency and/or reprogramming.   The location and 
pattern of staining was described by qualitative analysis.  
Analysis of the extent and strength of positive osteocalcin (OCN) staining was 
performed using a semi-quantitative scoring system based on that described by Dulay et 
al (125).  Three cell types were identified for analysis: 1) amnion epithelial cells 2) 
amnion fibroblasts 3) chorionic stromal cells.  The extent of staining was expressed on a 
graded scale of 0 to 5 (from 0% of cells with positive staining to 100% of cells with 
positive staining) and intensity was expressed on a graded scale of 0 to 5.  The 
osteocalcin score (OCN score) was then calculated as Σ(E+1)(i+1) where E represents 
extent and i represents intensity.  Thus the minimum OCN score is 3 and the maximum is 
108.  Results were analyzed by 2-way ANOVA (by PPROM status and level of HA 
staining). 
 
5.5 OptiCell  experimental culture of AF.  
Fresh AF was collected prospectively from women who presented with PPROM 
or symptoms of preterm labor without clinical evidence of infection (n=10).  Samples 
were centrifuged immediately at 3000g for 30 min at room temperature and the cell-free 
supernatant was sterilized by filtration with 0.22µm filters (Millipore). 1mL of filtered 
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AF in 9mL of Dulbecco’s Modified Eagle’s Medium (DMEM; Gibco BRL, Maryland) 
was injected into an OptiCell chamber (Nunc, Rochester, NY) as described by 
Tsurumoto et al. (77).  Duplicate chambers	  were prepared for each AF sample, and 10% 
sterile water in DMEM was used as a control.  Samples were incubated under 
mammalian cell culture conditions  (37C, 5%CO2/95% air) for 16 weeks or until 
evidence of CNP formation was observed by light microscopy.  Every 7 days, 100ul of 
sample was withdrawn and stored at -80C, and chambers were weighed to determine 
evaporative losses. Additional DMEM was added as necessary to replace loss due to 
evaporation and sampling. 
To determine the potential effect of storage conditions on the growth of CNP, 
1mL aliquots of the remaining sterile-filtered AF were prepared and stored at -80C. After 
2 weeks of storage, 4 additional chambers (n=4) were prepared as previously described. 
At the end of the incubation period, chamber contents were harvested.  Fluid 
contents were withdrawn from each chamber, and particles adherent to the inside surfaces 
of the plastic membranes were scraped and added to the withdrawn fluid.  The fluid was 
spun at 5000 rpm at room temp for 15 mins.  The supernatant was removed and stored at 
-80C.  The remaining pellet (putative CNPs) was washed 3 times in DMEM, resuspended 
in 200µL DMEM, and stored at -80C.    
 
5.6 Light microscopy of cultured AF-CNPs. 
Chambers were observed on a weekly basis by high-powered digital microscopy.  
Three images at 40.6x of each chamber were obtained from the center, top left, and 
bottom right corners of the visible field, at the initiation and conclusion of the culture 
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period.  To quantify the growth of nanoparticles over time, images were also obtained in 
one-week intervals from three amniotic fluid samples (n=4 chambers) and one pseudo-
amniotic fluid control until the completion of the incubation period.  Using ImageJ 
analysis software (available at http://rsb.info.nih.gov/ij; developed by Wayne Rasband, 
NIH, Bethesda, MD), each image was made binary using a threshold value consistent 
between time points, and the mean pixel density was calculated.  Because nanoparticle 
growth was not uniform throughout the chamber, the density of nanoparticles at each 
time point is reported as the mean pixel density averaged over three locations. 
 
5.7 Electron microscopy of cultured AF-CNPs. 
 All electron microscopy procedures were performed by the staff of the Yale 
Center for Cellular and Molecular Imaging. 
Glow discharged carbon coated formvar grids were placed on a drop of sample 
for 5 minutes, rinsed briefly on a drop of water then placed on a drop of 1% aqueous 
uranyl acetate for 2 minutes. Grids were blotted dry on filter paper.   
Samples were fixed in 4% paraformaldehyde and 0.1% gluteraldehyde in 10mM 
Hepes containing 0.9% sodium chloride for 1 hour, rinsed in buffer and re-suspended in 
10% gelatin, chilled and trimmed and placed in sucrose overnight at 4C. They were 
frozen rapidly on to aluminum pins in liquid nitrogen. The frozen block was trimmed on 
a Leica Cryo-EMUC6 UltraCut and 65-75nm thick sections were collected using the 
Tokuyasu method (126). The sections were collected on a drop of sucrose, and placed on 
a nickel formvar/carbon-coated grid. 
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Grids were placed section side down on drops of 0.1M ammonium chloride to 
quench untreated aldehyde groups, then blocked for nonspecific binding on 1% fish skin 
gelatin in PBS.  Single labeled grids were incubated on either a primary antibody rabbit 
anti-IL6 (Abcam) 1:50, or mouse anti-albumin (Novus) 1:50, or goat anti-fetuin-A 
(Novus) 1:500 for 30 minutes. A rabbit anti-mouse bridging antibody 1:200 (Jackson) 
was used for the mouse primary and rabbit anti-goat for the goat primary 1:150 (Jackson) 
before rinsing and using 10nm protein A gold (UtrectUMC) for 30 minutes.  Double-
labeled grids used the primary goat anti-fetuin-A 1:500 and 5nm protein A gold followed 
by either mouse anti-albumin 1: 30 or rabbit anti-IL-6 1:25 and the 10nm protein A gold.  
All grids were rinsed in PBS, fixed using 1% gluteraldehyde and transferred to a 
UA/methylcellulose drop, then dried for viewing. All samples were viewed FEI Tencai 
Biotwin TEM at 80Kv. Images were taken using Morada CCD and iTEM (Olympus) 
software.  
 
5.8 Red blood cell lysis (cytotoxicity) assay.   
Whole blood from 3 patients was collected in a blue top citrate tube.  Blood was 
diluted in PBS (1:5) and spun at 3000 rpm for 5 min at 4C.  Plasma supernatant was 
discarded and the RBC pellet was resuspended in 1.5 ml PBS.  The sample was spun and 
washed in PBS 4 times.  The RBC pellet was resuspended in 1ml DMEM after the last 
wash.  10µl of the resuspension was added to 190µl of treatment medium.  Treatments 
were prepared using native AF, cultured AF medium, HA nanoparticles (Sigma) of 
varying concentrations in DMEM, or HA nanoparticles of varying concentrations in the 
presence of bovine serum fetuin-A (100µg/ml, Sigma).  Treatments were plated in 
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duplicate on a spectrophotometry plate and incubated overnight at 37°C.  Images were 
obtained from 3 random locations of each well with 40X objective.  The number of RBCs 
per high-powered field were counted and averaged for each well.   
 
5.9 Amniochorion explant system.  
Amniochorion samples were obtained from healthy women (n=7) without any 
significant past medical history undergoing scheduled, elective Cesarean delivery in the 
absence of labor (GA: 38-40 wks). Indications for abdominal delivery included elective 
repeat or primary Cesarean delivery for fetal malpresentation (i.e. breech) or prior uterine 
scar.  No patient had abnormal placentation (i.e placenta previa, abruption).  All of their 
infants were appropriately grown for GA and had reassuring fetal heart rate patterns prior 
to surgery.  Biological sample collection was performed by the clinical team at the time 
of delivery.   
The setup for the amniochorion culture system was established based on 
previously published procedures (127,128).  Membranes were harvested distal from the 
point of iatrogenic rupture under sterile conditions and dissected free from the placenta 
within 10 min of delivery.  Ten-mm-diameter pieces were washed thoroughly to 
eliminate blood clots using cold RPMI medium 1640 (Gibco).  One piece of fetal 
membrane tissue was placed into each well of a 24-well tissue culture dish in 1ml of 
RPMI. Membranes were initially maintained in this medium for 6h (37°C, 5% CO2-95% 
air) prior to treatment.  Subsequently, the RPMI media was removed, and treatments were 
added in triplicate.  Treatments were prepared using native AF, cultured AF medium, AF-
derived CNPs, HA nanoparticles (Sigma) of varying concentrations in DMEM, or HA 
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nanoparticles of varying concentrations in the presence of bovine serum fetuin-A 
(100µg/mL, Sigma), and DMEM alone as control. 
Aliquots of 100ul were sampled from duplicate wells at 2, 5, and 18 hours.  After 
24h of incubation, the supernatants were collected, centrifuged to remove cellular debris 
and stored at –80ºC. The incubated tissue was homogenized in 1-ml cell extraction buffer 
(20mmol/l Tris-HCl, 150mmol/l NaCl, 1% Triton X-100, 1mmol/l phenylmethylsulfonyl 
fluoride, and complete protease inhibitor cocktail (Roche, Indianapolis, IN).  Specimens 
were spun at 1000g at 4°C for 15 min. and protein quantification of incubated tissue 
performed using Bicinchoninic acid (BCA) protein assay (Pierce Biotechnology, 
Rockford, IL) according to the manufacturer’s instructions. To correct for variations in 
tissue incubated per each well, the explant medium concentration of the sought analyte 
(IL-6, MMP-9, PGE2, LDH, glucose) was normalized to total protein in the tissue extract. 
For each experimental condition, values were derived by averaging normalized values 
from duplicate wells.   
Tissues from the triplicate well were collected at the end of the incubation period, 
fixed in formalin and embedded in paraffin. Masson’s Trichrome stain (Chromaview) 
was performed on 5-µm deparaffinized, rehydrated tissue sections, and the extent of 
cellular necrosis was determined based on conventional histological criteria.  Tissues 
were semi-quantitatively scored for the extent of cellular necrosis.  To assess collagen 
fiber length and architecture, Picrosirius Red staining was performed on 5-µm 
deparaffinized, rehydrated tissue sections using a standard protocol. 
Immunohistochemistry for osteocalcin was also performed using the protocol outlined 
previously.   
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5.10 Immunoassay procedures.  
ELISA assays for fetuin-A (BioVendor, Candler, NC) osteocalcin (Biomedical 
Technologies, Stoughton, MA) albumin (Bethyl Laboratories, Montgomery, TX), IL-6 
(eBioscience, San Diego, CA) and MMP-9 (R&D Systems) were performed to measure 
their levels in native AF, cultured AF, and/or explant media samples. The assays were 
run in duplicate according to the manufacturer’s protocols.  AF samples were diluted to 
1:1000 (fetuin-A), 1:50,000 (albumin), or 1:100 (IL-6, MMP-9) to fall within the range of 
the standard curve.  No dilution was used for the osteocalcin ELISA.  All plates were 
read by VERSAmaxTM microplate reader with Softmax Pro 3.1.1 software at the 
manufacturer’s recommended wavelength(s).  The inter- and intra-assay coefficients of 
variation were <10% for all sought analytes.  
 
5.11 Biochemical assay procedures. 
Total protein was measured by BCA Protein Assay (Thermo Scientific). 
Biochemical assays for ionized calcium (Pointe Scientific, Canton, MI) and inorganic 
phosphate (BioAssay Systems, Hayward, CA) were performed to measure their levels in 
native AF, cultured AF, and/or explant media samples.  A standard curve for calcium was 
prepared from a 500 mM standard (BioVision, Mountain View, CA).  Glucose was 
measured in the explant media samples using a quantitative enzyme-colorimetric assay 
(Stanbio, Boerne, TX).  PGE2 levels were determined in the explant medium by a 
competitive binding assay (R&D Systems) and results were expressed as fold-change 
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from basal levels. For all assays, samples were undiluted and run in duplicate. The inter- 
and intra-assay coefficients of variation were <10% for all analytes. 
 
5.12 Quantitative real time RT-PCR procedure.  
Expression of fetuin-A, RUNX2, osteocalcin and alkaline phosphatase mRNA in 
the fetal membranes collected from term (n=4) and preterm (n=5 PPROM, n=6 intact 
membranes) deliveries was analyzed by RT-PCR.  All women delivered in the absence of 
IAI or histological chorioamnionitis.   
Immediately after delivery, tissues were frozen in liquid nitrogen and kept at -
80°C. RNA was extracted and reverse transcribed into cDNA with random hexamer 
primers using standard procedures. Quantitative RT-PCR was performed using TaqMan® 
(Applied Biosystems) chemistry in 20 µL reactions composed of 10 µL mastermix 
(TaqMan® Fast Universal PCR 2x Master Mix), 8 µL water, 1µL cDNA template 
normalized and 1 µL PCR probe set (TaqMan® Gene Expression Assays on Demand). 
For the detection of fetuin-A (hs00155659_m1), RUNX2 (hs00231692_m1), osteocalcin 
(hs01587814_g1), and bone-specific alkaline phosphatase (hs01029144_m1) mRNAs, 
TaqMan® probes from Applied Biosystems were used. For controls, we used Taqman® 
probes hs99999907_m1 (β-2 microglobulin, B2M) and hs00265497_m1 (and ribosomal 
protein L30, RPL30). The combination of the two endogenous control mRNAs (B2M and 
RPL30) was validated in preliminary experiments using pools of cDNA amplified in the 
TaqMan® Human Endogenous Control Plate (Applied Biosystems). Selection of the two 
reference genes was based on low cycle threshold (Ct) values that were not different 
among the six cDNA pools. 
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For each target, amplification was performed in duplicate reactions in a 2-step 
cycle (denaturation, 95°C for 15 seconds, annealing/extension at 62°C for 60 seconds) for 
40 cycles. Post-processing calculations were performed using the StepOne Software 
(v2.1). The values obtained were normalized to the geometric mean of the endogenous 
control RNAs using calculations of ΔCt (Ct of the target – Ct mean of endogenous 
controls). A ΔCt of 0 indicates a ratio of 1 between the target and housekeeping genes. 
This ratio may be used as an indication of relative abundance between different targets 
among different tissues.  Calculation of ΔΔCt (ΔCt of individual sample –ΔCt of same 
target in reference sample) adds an additional normalization within targets.  Therefore, 
ΔΔCt improves estimation of relative mRNA abundance among different biological 
groups.   
 
5.13 Statistical analysis. 
Data were tested for normality using the Shapiro-Wilk test.  Results were reported 
as either mean with SEM or median with IQR. Comparisons between two groups were 
performed using Student t tests or Mann-Whitney rank-sum tests, as appropriate. 
Multiple comparison procedures were performed using one-way or two-way ANOVA or 
Kruskal-Wallis ANOVA followed by Holm-Sidak or Dunn’s multiple comparisons.  
Correlations were explored using Pearson’s product moment rank-order.  Proportions 
were compared with χ2 or Fisher’s exact tests. Statistical analyses were performed with R 
v2.15.2 (http://www.R-project.org/) and GraphPad Prism (version 6.0a).
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6. RESULTS 
6.1 HA and fetuin-A co-localize in placental villous and amniochorion tissues in 
patterns resembling CNPs. 
We began our investigation by staining for the presence of calcium deposition in 
placenta and amniochorion tissues collected from preterm and normal term deliveries.  
To remain broad in our scope of investigation, we selected tissue samples provided by 
women in our rule-out infection amniocentesis prospective cohort without bias to their 
clinical risk factors for spontaneous preterm birth including the presence of IAI and/or 
PPROM.  
We used two staining methods, Von Kossa and Alizarin S, to stain for calcium 
mineralization.  The von Kossa method identifies insoluble phosphate and carbonate salts, 
whereas Alizarin S confirms the presence of calcium; both methods have been used to 
demonstrate the presence of hydroxyapatite.  Qualitative analysis of HA staining 
demonstrated specific patterns of deposition in the placenta and amniochorion tissues of 
women with both preterm and term births.   
Specific Aim 1: To investigate the presence of CNPs and/or ectopic osteogenesis in 
the reproductive tissues of women with pregnancies complicated by spontaneous 
preterm birth. 
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Figure 4. Patterns of HA deposition in reproductive tissues. 
HA staining patterns in placenta and amniochorion (von Kossa stain, eosin counterstain) 
(a-f).  Three patterns were identified in placenta: plaques (a), granules (b), and linear 
deposits (c).  In the amniochorion, plaques (d) and granules (e) localized primarily to the 
collagenous matrix of the chorion, and finely dispersed particles (f) were present in the 
amnion epithelial layer and in the extracellular matrix of the compact layer. All scale bars 
= 50 µm. HA = hydroxyapatite. PL = placenta.  FM = fetal membranes.  
 
Three patterns were observed in the placenta: plaques, granules, and linear 
deposits (Fig. 4).  All patterns were identified in terminal villi and the stromal core of 
anchoring villi.  Linear staining was most often observed in the basement membrane of 
the syncytiotrophoblast layer of terminal and anchoring villi.  Granular deposits and 
plaques were observed in the extracellular matrix and in the cytoplasm of trophoblasts.  
Our observations of placental calcification patterns are consistent with those of a recently 
published case report by Pasquinelli et al, who demonstrated the presence of 
nanobacteria-like formations in placental villous tissue (83).   
We also identified novel hydroxyapatite staining patterns in the amniochorion of 
preterm deliveries.  The three major observed staining patterns can be characterized as 
plaques, granules, and finely dispersed particles.  Plaques and granules were 
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predominantly located in the collagenous ECM of the amnion compact layer, whereas 
finely dispersed particles were observed in the amnion epithelia and in the compact layer.  
Finely dispersed particles are minute, dot-like formations associated with the 
extracellular matrix, whereas plaques and granules stain more heavily, are less uniform, 
and are often located within collagenous “whorls” at the junction of amnion and chorion. 
Because the observed amniochorion calcification patterns displayed features 
characteristic of CNPs, we next sought to determine whether fetuin-A, a known 
component of both soluble and tissue-bound CNPs, was also present.  We identified 
intense fetuin-A immunoreactivity in all staining patterns observed in the placenta and 
amniochorion.  Figure 5 demonstrates positive von Kossa, Alizarin S, and fetuin-A 
immunostaining on serial sections of a representative placental villus.  Furthermore, 
strong fetuin-A immunoreactivity was also demonstrated along the fetal vascular 
endothelial surface and within the vascular lumen, which is consistent with its high 
concentration in fetal serum. 
 
Figure 5. Co-localization of calcium, phosphate, and fetuin-A. 
Co-localization of major CNP components, i.e. phosphate/carbonate (von Kossa with 
eosin counterstain), calcium (Alizarin S), and fetuin-A (immunohistochemistry by Vector 
NovaRed chromogen and Hematoxylin counterstain), in serial sections of placenta. Scale 
bar = 50 µm. PL = placenta. 
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6.2 Among idiopathic PTB cases, HA deposition is more prevalent in fetal membranes 
of idiopathic PPROM. 
Next, we aimed to investigate the relationship between positive CNP deposition, 
PPROM, and histological chorioamnionitis.  We used a simple ordinal scoring system 
from 0 to 2 to rate the extent and severity of calcification (HA score).  Over two-thirds of 
the placental sections studied in our preterm birth cohort had moderate to heavy 
calcification, defined as an HA score of 1 or 2 (Fig. 6, next page).  Analysis of the 
placental sections collected from term cesarean deliveries indicated positive HA staining 
in an equivalent number of cases (61% term versus 64% preterm).  Furthermore, we 
found no significant difference in placental HA scores between study groups.  These 
findings are consistent with prior reports that the presence of placental calcification on 
histological analysis is a common finding and that its clinical significance is unknown. 
However, a significantly smaller proportion of amniochorion sections displayed 
positive HA staining compared to placental villous sections (24% vs. 64% of the preterm 
cohort, χ2 test, P<0.001).  Furthermore, the distribution of amniochorion HA scores  
varied significantly between study groups (χ2 test, P<0.03).  Interestingly, we found that 
in the absence of HCA, positive HA staining was observed in a greater proportion of 
PPROM samples (45% [13/29]) than samples with intact membranes (15% [3/20], 
P<0.01) or term controls (17%, [3/18], P<0.01).  This stands in contrast to samples with 
HCA, in which positive HA staining was found in 25% (12/48) of cases, with no 
significant difference by membrane status or compared to term controls.  
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Figure 6. Proportion of cases with positive HA scoring by study group.  
A. Proportion of cases by HA score in matched preterm placental and amniochorion 
samples.  Over two-thirds of preterm placental samples demonstrated positive HA scores 
(score of 1 or 2) versus approximately one-quarter of amniochorion samples (χ2 test, 
P<0.001). B. Osteocalcin (OCN) immunostaining was more conspicuous in cases with 
more HA deposits (P<0.01).  Groups marked with different letters are significantly 
different at P<0.05. PL = placenta. FM = fetal membranes. HCA = histological 
chorioamnionitis. 
 
6.3 Fetuin-A is abundant in the AF of pregnant women and is regulated by gestational 
age. 
Demographic clinical and outcome characteristics of the women who provided 
amniotic fluid samples are presented in Table I (next page).  Women undergoing second-
trimester amniocenteses for genetic testing were significantly older than those undergoing 
amniocentesis for lung maturity testing in the third trimester or for rule-out infection.  
Women who underwent amniocentesis for lung maturity testing were of a greater 
gestational age, parity, and gravidity.  Given the circumstances surrounding 
amniocentesis for rule-out infection, women in this group were more likely to present 
with uterine contractions, cervical dilation greater than 3 cm, and PPROM.  
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All women undergoing amniocentesis for genetic testing in the second trimester 
had term births, as dictated by our selection criteria for this study group, whereas only 
17% of women undergoing amniocentesis for rule-out infection delivered at term.  Sixty-
two percent of women undergoing lung maturity testing in the third trimester had 
reassuring AF fetal lung maturity test results (defined as an L/S ratio greater than 2.5) 
which, in addition to other clinical considerations, likely resulted in less than half of 
women in this study group delivering at term (47%).   The amniocentesis-to-delivery time 
interval was significantly longer in the second-trimester group compared to rule-out 
infection or third-trimester controls, as would be expected given their earlier 
amniocenteses and proportion of term deliveries. 
Table I. Demographic and outcome characteristics of the women who provided AF 
samples (n=203). 
Variable 
Second-
trimester 
Genetic 
Testing 
Amniocenteses 
n=40 
Third-trimester 
Lung Maturity 
Amniocenteses 
n=37 
Rule-out 
Infection 
Amniocenteses 
n=126 
P 
value 
Characteristics at amniocentesis 
Maternal age, yearsa 33[28-37] 28[24-31] 28[22-33] 0.016 
Parityb 1[0-1] 1[1-2] 1[0-1] 0.026 
Gravidityb 2[1-3] 3[2-4] 2[1-4] 0.047 
Gestational age at amniocentesis, wksa 18[17-20] 36[36-37] 29[25-31] <0.001 
Uterine contractionsb 0 (0%) 0 (0%) 63 (50%) <0.001 
Cervical dilation > 3cmb 0 (0%) 1 (3%) 41 (33%) <0.001 
PPROMb 0 (0%) 0 (0%) 53 (42%) <0.001 
Clinical chorioamnionitisb 0 (0%) 0 (0%) 9 (7%) 0.078 
Outcome characteristics 
Term delivery (≥37 wks)b 40 (100%) 17 (46%) 22 (17%) <0.001 
PTB at < 34 wksb 0 (0%) 0 (0%) 98 (78%) <0.001 
GA at delivery, weeksa 39[38-40] 37[36-37] 31[27-33] <0.001 
Amniocentesis-delivery interval, daysa 143[135-153] 2[1-3] 3[1-18] <0.001 
aData presented as median [interquartile range] and analyzed by Kruskal-Wallis Rank Sum test. 
bData presented as number (percent) and analyzed by χ2 test. 
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Analysis of gestational age regulation of fetuin-A was performed using genetic 
(n=40), lung maturity (n=37), and rule-out infection amniocentesis samples from women 
who ultimately delivered at term (n=22).  These results are presented in Table I.  Fetuin-
A was constitutively present in human AF across the gestational period. Levels of fetuin-
A were inversely correlated with gestational age, with lower levels approaching term (Fig. 
7, R=-0.4104, P<0.001, next page).   
 
6.4 Idiopathic PPROM is characterized by selective AF protein depletion.  
The demographic, clinical, and laboratory characteristics of the preterm women 
are presented in Table II (next page).  PPROM women were significantly older, 
irrespective of IAI status (2-way ANOVA, PPROM: P<0.001, IAI: P=0.316).  
Gestational age at amniocentesis was influenced by both membrane status and the 
presence of IAI; PPROM was associated with later gestational age, and IAI was 
associated with an earlier gestational age (2-way ANOVA, PPROM: P=0.002, IAI: 0.02).  
PPROM and IAI were both associated with a significantly shorter amniocentesis-to-
delivery time interval (2-way ANOVA, PPROM: 0.002, IAI: P<0.001, interaction: 
P<0.05).  Birthweight did not differ significantly between groups.  The results of the 
biochemical and microbiological studies of the AF demonstrated lower glucose, higher 
LDH activity, and higher WBC counts in patients with IAI, irrespective of membranes 
status (IAI: P<0.001 for both analytes).   
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Table II. Demographic, clinical, laboratory and outcome characteristics of women with 
symptoms of preterm labor or PPROM who provided amniotic fluid samples (n=126). 
 
 
aData presented as median [interquartile range] and analyzed by Kruskal-Wallis Rank Sum test. 
bData presented as number (percent) and analyzed by χ2 test. 
 
 
 
 
Variable 
No IAI & 
Intact 
n=47 
No IAI & 
PPROM 
n=27 
Yes IAI & 
Intact 
n=26 
Yes IAI & 
PPROM 
n=26 
P 
value 
Clinical and outcome characteristics 
Maternal age, yearsa 26[20-32] 30[25-32] 25[21-31] 32[25-37] 0.009 
Paritya 1[1-2] 1[0-1] 0[0-1] 1[0-3] 0.339 
Graviditya 2[1-3] 2[1-3] 3[1-3] 3[2-5] 0.379 
History of preterm birthb 10 (21%) 9 (33%) 7 (27%) 7 (27%) 0.7258 
Gestational age at 
amniocentesis, wksa 
29[24-31] 30[29-31] 25[24-28] 29[26-31] 0.003 
Expectant managementb 43 (91%) 21(78%) 13 (50%) 9 (35%) <0.001 
Amniocentesis-delivery 
interval, ha 
573[96-1455] 117[37-240] 5[4-10] 15[7-60] <0.001 
Amniocentesis-delivery < 7db 16 (34%) 16 (59%) 23 (88%) 24 (92%) <0.001 
Birthweight, ga 1615 
[1360-2020] 
1575 
[1135-2110] 
2007 
[1671-2269] 
1850    
[1571-1952] 
0.330 
Contractionsb 28(60%) 5 (19%) 19 (73%) 11 (42%) <0.001 
Cervix dilated > 3cmb 15(32%) 2 (7%) 18 (69%) 6 (23%) <0.001 
Clinical chorioamnionitisb 0 (0%) 0 (0%) 2 (8%) 7 (27%) <0.001 
Clinical and outcome characteristics 
Glucose, mg/dla 30[24-41] 27[20-37] 4[2-14] 8[2-18] <0.001 
LDH activity, U/la 163 
[124-249] 
124 
[104-218] 
782 
[519-1022] 
629 
[431-912] 
<0.001 
WBC count, cells/mm3a 3[1-6] 6[2-13] 679[133-1380] 507[64-2128] <0.001 
Positive Gram stainb 0 (0%) 0 (0%) 13 (50%) 10 (38%) <0.001 
Positive culturesb 1 (2%) 0 (0%) 13 (50%) 20 (77%) <0.001 
Placental histology results  
(n=93) 
n=19 n=24 n=25 n=25  
Chorionic plate 
inflammation, stagea 
1[0-2] 0[0-2] 3[3-3] 3[2-3] <0.001 
Amnionitis, gradea 0[0-0] 0[0-0] 3[1-3] 2[2-3] <0.001 
Choriodeciduitis, gradea 2[0-3] 0[0-3] 3[2-4] 3[3-4] <0.001 
Funisitis, gradea 0[0-0] 0[0-0] 2[0-3] 2[0-4] 0.008 
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Table III. Absolute levels of AF total protein, fetuin-A, albumin, IL-6, MMP-9, 
osteocalcin, ionized calcium, and inorganic phosphate for women with preterm 
deliveries. 
 
Variable 
No IAI & 
Intact 
n=47 
No IAI & 
PPROM 
n=27 
Yes IAI & 
Intact 
n=26 
Yes IAI & 
PPROM 
n=26 
P value 
Total protein, mg/mL† 5.1[3.6-5.5] 3.6[2.7-4.4] 5.7[4.7-6.7] 4.5[3.1-6.0] <0.001 
Fetuin-A, µg/mL† 40.0[29.4-55.9] 21.3[14.0-31.5] 38.7[27.3-49.5] 25.2[18.4-31.3] <0.001 
Albumin, mg/mL† 1.7[1.2-2.8] 1.1[0.9-1.2] 2.0[1.8-2.4] 1.1[0.8-1.6] <0.001 
IL-6, ng/mL† 1.1[0.5-4.8] 0.5[0.2-0.8] 19.9[9.3-52.7] 12.7[7.5-27.8] <0.001 
MMP-9, ng/mL† 10.3[8.9-17.3] 9.0[8.3-11.8] 577[107-1235] 493[97-1126] <0.001 
Osteocalcin, ng/mL† 3.2[1.9-4.7] 3.6[2.7-6.7] Not measured Not measured 0.349 
Ionized calcium, mM† 1.5[1.4-1.6] 1.5[1.3-1.7] 1.5 [1.3-1.6] 1.3[1.1-1.6] 0.117 
Inorganic phosphate, mM† 0.3[0.2-0.5] 0.4[0.3-0.5] 0.5[0.3-0.7] 0.5[0.3-0.7] 0.072 
   † Data presented as median [interquartile range] and analyzed by Kruskal-Wallis Rank Sum test. 
The absolute values of all measured analytes in the AF of women who delivered 
preterm are presented in Table III. Total protein levels were elevated in women with IAI 
and reduced in women with PPROM (2-way ANOVA, IAI: P<0.01, PPROM: P<0.05).  
Levels of fetuin-A and albumin were significantly decreased in the AF of women with 
PPROM, independent of the presence of IAI (fetuin-A: PPROM: P<0.001, IAI: P=0.340; 
albumin: PPROM: P<0.001, IAI: P=0.46).  IL-6 levels were significantly elevated in 
women with IAI, consistent with its known role in the fetal inflammatory response, but 
were significantly lower in women with PPROM (PPROM: P<0.01, IAI: P<0.001).  
While MMP-9 was increased in the presence of IAI as expected, we found no association 
between MMP-9 and PPROM (PPROM: P=0.91, IAI: P<0.001).  All results maintained 
following correction for gestational age, with the exception of total protein; correcting for 
gestational age resulted in loss of statistical significance in relationship to PPROM 
(P=0.40). In summary, PPROM is characterized by a selective reduction in the CNP-
related proteins fetuin-A and albumin, as well as IL-6, a protein constitutively present in 
AF.  Figure 7 (next page) demonstrates the results of our investigation of total protein, 
fetuin-A, albumin, IL-6, and MMP-9 in AF samples.   
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Figure 7. Characterization of select protein markers in AF from all study groups.  
A-C. Levels of total protein, albumin, and fetuin-A studied by ELISA in AF of women 
enrolled in PTB study group. D-E. Levels of IL-6 and MMP-9. Data represented on 
logarithmic scale. F. Effect of gestational age on levels of fetuin-A in AF of women from 
control groups.  Groups marked with different letters are significantly different at P<0.05. 
Thick line represents the median value for the group. Data analyzed by Kruskall-Wallis 
ANOVA with Dunn’s multiple comparisons. GA= gestational age. IAI = intra-amniotic 
infection/inflammation. 
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We further investigated this phenomenon of protein depletion by normalizing 
each analyte to total AF protein.  Results of this analysis are represented in Figure 8.  In 
cases of idiopathic preterm birth, fetuin-A, albumin, and IL-6 levels are significantly 
lower in PPROM.  Furthermore, we found a significant direct correlation between fetuin-
A and albumin (Pearson r=0.702, P<0.001) and fetuin-A and IL-6 (R=0.343, P=0.01) 
levels.  Interestingly, we found no difference in MMP-9 levels between intact membranes 
group and PPROM.  All results maintained following correction for gestational age.  In 
summary, PPROM is characterized by the selective and proportional decrease of 
abundant proteins (fetuin-A and albumin) and endogenous proteins of smaller quantity 
(IL-6). 
 
Figure 8. Selective depletion of AF proteins in idiopathic PTB cases with PPROM. 
Levels of fetuin-A, albumin, IL-6, and MMP-9 normalized to total protein in women 
without IAI. Fetuin-A, albumin, and IL-6 but not MMP-9 are selectively reduced in cases 
with PPROM.  All results maintained following correction for gestational age. Thick line 
represents the median value for the group. Data analyzed by Mann-Whitney test.  Groups 
marked with different letters are significantly different at P<0.05.  
Measurable levels of ionized calcium and inorganic phosphate were found in the 
AF of women across all gestational ages and in the preterm birth cohort (Tables III and 
IV).  No significant relationships were discovered between levels of ionized calcium and 
gestational age, membrane status, or presence of infection.   
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Levels of inorganic phosphate were inversely correlated with gestational age, with 
lower levels approaching term (R=-0.775, P<0.001).  In preterm women, levels of 
inorganic phosphate were significantly elevated in the AF of women with IAI, 
independent of the presence of PPROM (2-way ANOVA, PPROM: P= 0.76, IAI: 
P<0.01).  This result maintained following correction for gestational age. 
To investigate the potential functional role of soluble OCN in cases of idiopathic 
preterm birth (absence of IAI), we measured OCN levels in the AF of women who 
ultimately delivered preterm in the absence of infection/inflammation.   OCN is present 
in the AF of these women but its levels are unaffected by PPROM.  
 
Table IV. Absolute levels of AF fetuin-A, ionized calcium, and inorganic phosphate for 
women with normal outcomes. 
 
 
Variable 
Second-
trimester 
Genetic Testing 
Amniocenteses 
n=40 
Third-trimester 
Lung Maturity 
Amniocenteses 
n=37 
Rule-out 
Infection 
Amniocenteses 
& term delivery  
n=22 
P value 
Fetuin-A, ug/mL† 33.8[23.3-40.3] 18.9[12.1-22.9] 30.1[21.9-52.3] <0.001 
Ionized calcium, mM† 1.4[1.3-1.5] 1.4[1.3- 1.6] 1.4[1.3- 1.6] 0.905 
Inorganic phosphate, mM† 0.6[0.4- 0.7] 0.2[0.2- 0.3] 0.2[0.2- 0.3] <0.001 
   † Data presented as median [interquartile range] and analyzed by Kruskal-Wallis Rank Sum test. 
 
6.5 Markers of ectopic osteogenesis are present in the amniochorion of human 
pregnancies complicated by PPROM. 
The presence of CNP footprints in vivo led us to consider the possibility that 
CNPs may play a specific role in amniochorion pathology and membrane rupture, 
particularly in idiopathic preterm birth cases uncomplicated by chorioamnionitis.  As 
previously discussed, extensive research in the field of tissue engineering has revealed 
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the potential of indigenous amniochorion cells for differentiating down multiple cell 
lineages in vitro.  HA, a major component of CNPs, is known to induce differentiation of 
mesenchymal cells into osteoblasts.  As proof-of-principle that the process of ectopic 
osteogenesis may play a role in membrane pathophysiology, we sought markers of 
osteogenic differentiation in samples affected by HA deposition.  
 
Figure 9. Osteocalcin is present in PPROM cases with evidence of HA deposition. 
(a) We observed intense OCN immunoreactivity in PPROM amniochorion samples that 
had also stained positive for HA.  No OCN immunoreactivity was observed in HA-
negative PPROM tissues (b) or in HA-negative iatrogenic preterm birth controls (c).  HA 
= hydroxyapatite. OCN = osteocalcin. All scale bars = 50 µm. 
 
Osteocalcin (OCN) is a highly specific marker for the osteoblast cell, and its 
presence has been demonstrated in soft tissues affected by ectopic osteogenesis.  We 
initially asked whether tissues demonstrating HA positivity also expressed OCN.   In HA-
positive tissue samples, we observed intense OCN positivity in cytoplasmic granules of 
amnion cells scattered within the highly collagenous compact layer (Fig. 9).  We did not 
observe this positivity in HA-negative sections from either PPROM cases or iatrogenic 
preterm birth controls.   
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Next, we investigated expression of other markers of ectopic osteogenesis at 
various points in the sequence towards mature osteoblastic differentiation, including early, 
essential transcription factors (RUNX2, osterix [OSX]) as well as non bone-specific 
markers of osteoblastic function (osteopontin [OPN], osteonectin [ONN]) (Fig. 10, next 
page) (98).  RUNX2 and OSX were expressed in both PPROM cases and iatrogenic 
preterm birth controls. Osteopontin, a protein with roles in wound remodeling and 
immunologic function that is elaborated by osteoblasts and other cell types, was 
demonstrated in PPROM cases but not controls (123).  Osteonectin, an ECM protein that 
binds collagen and increases production of MMPs (124), was found in both PPROM and 
control membranes localized to chorionic trophoblasts, albeit staining intensity was 
higher in PPROM cases. 
Tissue expression of mRNA for RUNX2, OCN, and bone-specific alkaline 
phosphatase was present in human amniochorion but levels did not differ with membrane 
status.  This is likely due to the delay in tissue sampling at delivery relative to the 
initiation of the osteogenic differentiation sequence.  In addition, OCN mRNA undergoes 
significant post-translational modification, which was not investigated in this study. 
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Figure 10. Immunolocalization of markers of the osteogenic differentiation sequence 
in human fetal membranes of idiopathic PPROM versus iatrogenic PTB. 
 
RUNX2 and OSX were expressed in both PPROM (a&b) and controls (e&f). OPN was 
found in PPROM (c) but not in controls (g). ONN was found in both PPROM (d) and 
control membranes localized to chorionic trophoblasts (h), albeit staining intensity was 
higher in PPROM. Arrows point to ONN+ indigenous cells in the amnion. Scale bars: 50 
µm. 
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Next, we sought other developmental markers to further describe the differentiation state 
of OCN-positive cells (fibroblasts) within the amnion compact layer. We identified two 
different types of cell populations that were OCN-positive: large round cells with 
granular inclusions with CDX2 positivity and small elongated cells with SOX2 positivity 
(Fig. 11).  CDX2 is a transcription factor expressed very early in embryonic development 
that differentiates the trophectoderm cell lineage of the developing blastocyst(129); its 
presence in this cell population indicates a subset of multipotent, partially differentiated 
cells.  SOX2 expression is essential for osteoblasts to maintain their ability to proliferate 
(99).  Its presence indicates a subpopulation of reprogrammed, unipotent osteoblastic 
cells that are capable of self-renewal.  In summary, amnion fibroblasts express markers at 
various points in the path towards osteogenic differentiation—from early 
trophectodermal cells to mature osteoblasts.	  
 
Fig. 11. OCN-positive cells in amnion of PPROM cases and hydroxyapatite (HA) 
deposition express markers of early differentiation and reprogramming. Representative 
OCN staining patterns in PPROM cases with HA deposition (HA+). OCN positivity was 
localized to the cytoplasm of cells scattered within the compact layer of the amnion. Two 
different types of cell populations could be identified: large round cells with granular 
OCN-positive inclusions that also stained positive for CDX2 (a,b) and small elongated 
cells that also stained for SOX2. Positive nuclear staining for CDX2 (b) and SOX2 (d). 
HA(+) = HA score 1 or 2. Scale  bars: 50 µm.  	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6.6 Putative CNPs aggregate in AF and essential organic and inorganic components of 
AF are depleted in the process. 
Given the results of our investigation of AF and amniochorion CNP constituents, 
we aimed to investigate the capability of AF to produce CNPs in vitro.  We adapted our 
procedure based on methods outlined by Tsurumoto, et al., in their analysis of synovial 
joint fluid (77).  After the 16-week culture period, all AF fluids demonstrated growth of 
nanoparticles to varying degrees.  Nanoparticle growth was characterized by the 
appearance of an opaque film, the density of which varied across the OptiCell chamber.  
By light microscopy, round particles of less than 1 micron in diameter were observed.  
Some of these particles appeared to be static and adherent to the inner surface of the 
OptiCell, while other particles exhibited random motion consistent with a colloidal 
solution.  
Nanoparticle formation was observed between 4 and 16 weeks, and a majority of 
(7/10) AFs demonstrated growth by evaluation under light microscopy after 8 weeks (Fig. 
12, next page).  Serial image analysis showed that the rate of CNP formation varied 
between amniotic fluids.  However, the rate of growth between duplicates was consistent.  
Nanoparticles were observed in both fresh and frozen samples, and freezing did not have 
an appreciable effect on the time to CNP formation.  CNP pellets were obtained from all 
(10/10) AF samples after centrifugation of incubated AF media.   
Specific Aim 2: To experimentally determine the capability of human AF to 
generate CNP aggregates. 
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Figure 12. Kinetics of CNP growth in vitro.  
A. Growth of putative CNPs was observed after 8 weeks in most (7/10) AF samples by 
light microscopy and growth was exponential.  Note agreement between duplicates (AF 
3a and 3b). N=10 preterm patients (3 AFs illustrated). B. CNPs by light microscopy after 
16 weeks of incubation of AF#1. C. Control sample containing 10% sterile water in 
DMEM did not demonstrate CNPs by light microscopy or centrifugation after 16 weeks. 
All scale bars = 30 µm.  
 
We also incubated pseudo-amniotic fluid as a control, which was prepared with 
bovine serum albumin, a protein that has also been implicated in CNP formation.  
Crystalline structures were observed at approximately 5 weeks in pseudo-AF cultures.  
However, these structures had a different morphology and size from those observed in 
AF, and they did not form a grossly visible opaque film.  Furthermore, they did not 
increase appreciably in size or number over time.  Cultures with sterile water did not 
show evidence of nanoparticle formation.     
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A number of factors present in the amniotic fluid at the start of incubation were 
depleted in the process of nanoparticle formation in vitro.  As shown in Figure 13, levels 
of components implicated in CNP formation, i.e. fetuin-A, ionized calcium, and inorganic 
phosphate, were significantly lower at the end of the incubation period (all P<0.001). 
Levels of IL-6 were also significantly lower after CNP incubation (95.9±0.1% decrease, 
P<0.001).  Conversely, glucose, which is present in the incubation medium, yet not 
typically present in amniotic fluid, was significantly increased from baseline (P=0.001).  
 
 
Figure 13. Depletion of soluble factors at the start and end of the CNP growth period.  
Levels of fetuin-A and IL-6 decrease significantly after CNP formation in vitro. Albumin, 
a highly abundant protein in amniotic fluid, tended to decrease during CNP formation, 
though this trend did not reach statistical significance.  Elemental components of CNPs 
(ionized calcium and phosphate) are also significantly decreased in the CNP growth 
media after CNP formation.  Glucose was doubled at the end of the incubation period, 
which is consistent with weekly replacement of the sampled media with glucose-
containing DMEM to maintain a constant volume.  (Wilcoxon matched-pairs test, groups 
with different letters represent P<0.05). S= Start. E= End. 
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6.7 Electron microscopy of nanoparticles demonstrate features consistent with CNPs. 
To determine the structure of AF nanoparticles, we isolated mature CNP particles 
from solution and viewed them under electron microscopy (Fig. 14).  Negative staining 
with uranyl acetate revealed round formations below 100nm in size, which is within the 
size range expected for CNPs.  Immuno-gold labeling with anti-fetuin-A antibody 
revealed the presence of fetuin-A exclusively within these particles, which appear grey. 
Double-immunolabeling for IL-6 and albumin demonstrates co-localization with fetuin-A. 
 
Figure 14. Electron and immuno-electron microscopy of CNPs and co-localization of 
fetuin-A, albumin, and IL-6. 
A. Negative staining by uranyl acetate B. Immuno-gold labeling demonstrates fetuin-A 
positivity within these particles (10nm black dots).  The mineral-protein component 
appears grey on a white background. C. Double-immunolabeling of fetuin-A (5nm) and 
albumin (10nm) demonstrates association within CNPs.  D. Fetuin-A (5nm) and IL-6 
(10nm) also co-localize. All scale bars = 50nm. 
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6.8 CNP intermediates demonstrate pro-apoptotic and matrix-degrading effects on 
explanted amniochorion tissue.  
 We used an amniochorion explant system to investigate the functional effect of 
AF-derived CNPs on amniochorion tissue.  Samples collected from term C-section 
deliveries (N=7) were treated with 1) native AF, 2) CNP aggregates developed over the 
16-week incubation period suspended in DMEM, and 3) the protein-poor supernatant 
containing putative immature CNPs (iCNPs) after centrifugation and removal of CNP 
aggregates.  Amniochorion treated with iCNPs demonstrated a significantly greater rate 
of glucose consumption at the 2hr timepoint compared to the protein-rich native AF 
(P<0.05).  Levels of IL-6 were significantly decreased by iCNP media at the 24hr time 
point (P<0.05).    Interestingly, production of PGE2, an important local mediator of labor 
induction and membrane rupture, was significantly increased in amniochorion exposed to 
iCNPs (P<0.05).  Taken together, these results implicate that the nutrient-poor iCNP 
media is potentially toxic, while mature CNP aggregates are non-toxic and similar to 
native AF.  Figure 15 (next page) demonstrates these results.  
Next, we explored the effect of iCNP treatment at the cellular and tissue level.  
Using a highly specific stain for collagen, Sirius Red, we investigated the effect of CNPs 
on the collagen content and structure of the same explants.  Under polarized light, thicker 
Specific Aim 3: To identify the pathways by which CNPs and/or ectopic 
osteogenesis may lead to membrane rupture and idiopathic spontaneous preterm 
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collagen fibers appear red and orange, while thinner fibers appear yellow and green. 
Amnion explants treated with native AF maintain thick collagen structures,  
 
 
 
 
 
 
 
 
whereas treatment with iCNPs results in thinning of collagen fibers and dissolution of the 
supportive matrix (Fig. 16, next page).  By Masson Trichrome stain, we also observed a 
relative reduction in collagen content and thickness in the compact layer (blue layer) with 
iCNP treatment, as well as sloughing of the amnion epithelium.   Immunoreactivity for 
TUNEL (dUTP nick end labeling) revealed DNA fragmentation indicative of apoptosis in 
AF iCNP CNP
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Figure 15. Functional effect of AF-CNPs on 
amniochorion explants. 
A. Glucose consumption represented as percent-
change from baseline glucose level. (2-way 
ANOVA, time, P<0.0001, treatment P=0.06).  
Amniochorion treated with iCNPs demonstrated a 
significantly greater rate of glucose consumption at 
the 2hr timepoint vs native AF.  Explants treated 
with iCNPs released significantly less IL-6 over 
time (2-way ANOVA, time P<0.0001, treatment: 
P<0.03).  Data were normalized to tissue protein 
and multiple comparisons analyzed by Holm-Sidak 
method.  B. A 3-fold increase in PGE2 production 
by iCNPs was observed compared to CNPs 
(P<0.05), but the relative increase compared to 
native AF did not reach statistical significance.	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amnion epithelium, which was not observed in the controls.  Finally we observed positive 
immunoreactivity for OCN in the cytoplasm of amnion fibroblasts treated with both 
native AF and iCNPs.  However, OCN immunoreactivity was additionally observed in 
the extracellular space in iCNP-treated amnionchorion.   
 
Figure 16. Effect of AF-CNPs on amniochorion explant histology. 
Representative sections of amniochorion treated by incubation with native AF (a-d) 
versus iCNPs (e-h). Sirius Red staining (a,e) under polarized light reveals dissolution of 
the normal collagen architecture and reduced thickness of the amnion compact layer. 
Masson Trichrome (b,f) reveals sloughing of the amnion epithelial layer.   
Immunoreactivity for TUNEL demonstrates DNA fragments indicative of apoptosis in 
amnion epithelial nuclei treated with iCNPs (c,g).  Immunoreactivity for OCN occurs in 
the cytoplasm of amnion fibroblasts treated with native AF (arrowhead), but stronger 
cytoplasmic and extracellular OCN immunoreactivity is observed in iCNP-treated tissue 
(arrow). iCNP = immature CNPs. OCN = osteocalcin. TUNEL = dUTP nick end labeling. 
All scale bars = 50µm. 
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Collectively, these results demonstrate that iCNPs compromise not only the function but 
also the structure of the amniochorion through mechanisms potentially involving nutrient 
deprivation, apoptosis, prostaglandin release, fibroblast differentiation, and destruction of 
the ECM. 
HA nanoparticles (Sigma, 200nm) were also applied to amniochorion explants in 
the presence and absence of fetuin-A in vitro.  A nearly 3-fold increase in PGE2 release 
by HA alone in the absence of fetuin-A was observed (HA: P<0.001, fetuin-A: P=0.25, 
interaction: P<0.01).  There was no significant change in PGE2 release with HA in media 
containing fetuin-A (Fig. 17).  MMP-9 immunoreactivity was not significantly affected 
HA concentration or the presence of fetuin-A.  However, we did observe a paradoxical 
inhibitory effect of HA at the lowest HA dose.    
 
 
Figure 17. Functional effect of exogenous HA on amniochorion explants. 
A. Amniochorion samples were treated with increasing concentrations of HA 
nanoparticles in the presence and absence of 100µg/ml of fetuin-A.  HA nanoparticles 
(high dose) induce PGE2 release from amniochorion explants, an effect inhibited by 
fetuin-A. B. MMP-9 immunoreactivity was not affected. A paradoxical inhibitory effect 
of HA was seen at the lowest dose (both on PGE2 and MMP-9). Data were analyzed by 2-
way RM ANOVA with Holm-Sidak multiple comparisons. 
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Figure 18. Effect of exogenous HA on ectopic osteogenesis of amniochorionic cells. 
A. In the absence of fetuin-A, HA nanoparticles (high dose) induce osteocalcin 
expression of amnion fibroblasts. In the presence of fetuin-A, osteocalcin expression is 
inversely related to the concentration of HA. OCN immunoreactivity from representative 
sections of amniochorion treated with high dose HA (C) versus untreated control (B) in 
the absence of fetuin-A.  
 
In the absence of fetuin-A, we observed a dose-dependent increase in the number of 
amnion fibroblast cells demonstrating positive OCN immunoreactivity (Fig. 18).  In the 
presence of fetuin-A, however, we observed an inverse dose-response relationship such 
that the number of OCN-positive cells decreases with the concentration of HA.  
    
6.9 CNP intermediates demonstrate red blood cell cytotoxicity in vitro.  
Results of the red blood cell cytotoxicity assay revealed an approximately 3-fold 
reduction in overall cell count due to incubation with iCNPs compared to native AF. 
(P<0.05) (Fig. 19, next page).  In the presence of exogenous HA, we observed a greater 
number of microcytic cells and increased number of acanthocytes characteristic of cell 
membrane stress.  However, in medium containing fetuin-A, HA nanoparticles aggregate 
into larger CNP-like structures and changes to cell size and shape were not noted.  
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Figure 19. Effect of AF-CNPs and exogenous HA on red blood cells.  
HA nanoparticles are cytotoxic to human RBCs (A), an effect inhibited by Fetuin-A 
which induces aggregation of HA nanoparticles in larger  structures (B). Dysmorphic 
RBCs (acanthocytes) are shown by the arrowheads. Scale bar: 30 µm. C-E. In the 
presence of iCNPs, RBCs exhibit cell lysis as represented by an approximately 3-fold 
reduction in overall cell count compared to RBC incubated with native AF. Groups with 
different letters signify P<0.05. RBCs = red blood cells.  All scale bars = 30µm. 
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6.10 CNPs bind the amyloidophilic dye Congo Red. 
CNP aggregates form pleiomorphic structures that bind Congo Red, a dye that 
creates supramolecular assemblies when binding to misfolded proteins.   Figure 20 (next 
page) demonstrates the ability of CNPs to bind Congo Red and exhibit characteristic 
birefringence of misfolded proteins under polarized light.  We observed pleomorphic 
structures that exhibited linear conformations and crystalline elements.  Under polarized 
light, these structures exhibited birefringence at a range of wavelengths in the visible 
light spectrum.  The characteristic apple-green birefringence of amyloid plaques was 
observed in some linear and crystalline formations.  The central core of CNP aggregates 
also appears birefringent without staining positive with Congo Red, which is consistent 
with prior studies that demonstrate a crystalline core, or nucleus, that can be found in 
CNP structures. 
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Figure 20.  CNP binding of the amyloidophilic dye Congo Red. 
CNP aggregates form pleiomorphic structures under white light (a-c), and the central 
core reflects polarized light in the blue-white spectrum (d-f). CNP aggregates bind the 
amyloidophilic dye Congo Red (g-i).  Under polarized light, these structures exhibited 
birefringence in multiple spectra (d-f).  The characteristic apple-green birefringence of 
amyloid plaques was observed in linear and crystalline formations (k,l). CR = Congo Red. 
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7. DISCUSSION 	  
 Preterm birth is the leading cause of neonatal morbidity and mortality, and it 
represents an enormous cost to our health care system and society.  Spontaneous preterm 
birth continues to be extremely difficult to predict or prevent, despite many efforts and 
health care dollars spent. By the time a patient presents with overt clinical manifestations 
of preterm labor or membrane rupture, the clinician’s tools are limited in altering the fate 
of the pregnancy.  The ability to identify patients at risk for preterm birth is critical to 
decreasing the rate of prematurity, but this has been hindered by a fundamental lack of 
understanding of the underlying pathophysiology that is likely underway long before a 
patient presents to the hospital with signs or symptoms of preterm birth.   
The current study began with a simple question: are CNPs a cause of preterm 
birth? Our initial investigation demonstrated highly specific patterns of microscopic 
calcification, co-localized with fetuin-A, in placenta and amniochorion that resembled 
CNPs described in the literature.  With a well-defined patient cohort, we demonstrated 
that this process occurred more often in amniochorion from patients with PPROM, 
particularly in the absence of histological chorioamnionitis.   
Tissue mineralization occurs due to the interplay of three determinants: 
extracellular matrix components suitable for mineralization, levels of inorganic phosphate 
and ionized calcium, and levels of mineralization inhibitors (produced locally or 
systemically) (86).  Disruption of this balance can lead to aberrant mineralization and 
deposition of CNPs.   We further investigated the hypothesis that CNP formation in the 
amniotic cavity precedes membrane rupture by measuring inorganic phosphate, calcium, 
and fetuin-A in amniotic fluid from our preterm birth cohort.  While we saw no 
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significant difference in levels of calcium or phosphate, we did demonstrate a significant 
reduction in fetuin-A in idiopathic PPROM cases. Collectively, these results suggested 
that the pathogenesis of idiopathic PPROM involves a significant disruption in the 
balance of factors involved in tissue mineralization.   
To better understand the mechanism of CNP-mediated protein depletion and the 
potential consequence of CNP deposition in amniochorion, we adapted a protocol 
described for the long-term culture of CNPs in synovial joint fluid.  After a period of 
weeks, we observed the formation of putative CNPs in cultured AF.  During the process 
of CNP formation, AF media had been depleted of essential proteins (fetuin-A, albumin), 
calcium, and phosphate, but not glucose, which is not known to be involved in CNP 
formation.  Electron microscopy demonstrated round formations containing 
predominantly fetuin-A along with other AF proteins.  This study is the first to provide 
evidence that AF harbors the capacity to generate CNPs in vitro.  Further investigation 
into the complex crystalline structure and composition of AF-derived CNP aggregates 
will be necessary to improve our understanding of their composition and method of 
formation. 
We tested the functional effects of AF-derived CNPs on amniochorion and found 
that the protein-poor, mineral-poor AF media was toxic to amniochorion, but mature 
CNP aggregates were relatively benign.  We suggest that the toxicity of CNP-depleted 
media may be two-fold: 1) depletion of homeostatic AF proteins and minerals results in 
cell starvation and activation of apoptotic and/or matrix-degrading pathways and 2) CNP-
depleted media contains toxic CNP intermediates (iCNPs) not removed by centrifugation.  
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To further characterize the nature of CNP toxicity, we applied pure  
hydroxyapatite nanoparticles to amniochorion in the presence and absence of fetuin-A, in 
an attempt to recapitulate the CNP formation process in vivo.  We saw a nearly 3-fold 
increase in PGE2 release by HA alone in the absence of fetuin-A, similar to that induced 
by iCNPs.  Furthermore, soluble fetuin-A nucleated HA macroscopically and prevented 
the release of PGE2.  Prostaglandins (PGs) are central to mediating the local effects of the 
inflammatory response: they induce myometrial contractility, alter the composition of the 
extracellular matrix in the cervix and amniochorion, and activate the maternal decidua. 
Importantly, PGs can stimulate the local production of MMPs in the fetal membranes and 
uterine cervix, which degrade the structural components of the extracellular matrix, 
including collagens and proteoglycans (130).  Finally, prostaglandin (PG)E2 and PGF2α 
alter the ratio of progesterone receptor isoforms resulting in reduced progesterone activity 
(131).  Our results suggest that exposed HA nanoparticles may directly affect membrane 
function through the induction of PGE2, and fetuin-A has a direct protective effect in 
neutralizing toxic HA species.  
Despite the observed dose-dependent increase in PGE2, we found that MMP-9 
levels were not affected by CNP treatment, which agreed with our in vivo observation 
that MMP-9 levels do not differ in PPROM cases compared to intact membranes in the 
absence of infection.   However, this finding does not preclude the involvement of MMP-
9 in the pathogenesis of PPROM in our proposed model.  In vitro data have shown that 
tissue-bound fetuin-A protects MMP-9 from degradation while preserving its 
gelatinolytic activity (132).  Furthermore, immobile, tissue bound fetuin can act as 
anchors for MMP-2 and MMP-9, an effect which is abrogated in the presence of soluble 
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fetuin (133).  It is possible that high local concentrations of immobilized fetuin-A created 
by CNP nucleation protect MMPs from degradation, thereby promoting catabolism of the 
extracellular matrix.  Finally, CNP deposits in the amniochorion may potentiate the 
degradation of the extracellular matrix through mechanisms independent of MMP-9 
activity.  
Nascent CNPs appear to be cytotoxic in vitro and disrupt the structure and normal 
function of the fetal membranes.  It logically follows that deposition of CNPs in fetal 
membranes brings in contact pluripotent amnion cells with deposited HA, which, based 
on the known literature, should serve as a stimulus for ectopic osteogenesis.  Histological 
analysis of idiopathic PPROM cases demonstrates that the amniochorion is affected by 
aberrant osteogenic differentiation of fibroblasts.  Not only does the deposition of HA 
potentially alter membrane fluidity, but it also alters the critical function of amnion 
fibroblasts, which are solely responsible for maintaining the collagen content of the 
compact layer, which provides the majority of the tensile strength of the amniochorion.  
Another possible relationship between CNP deposition and ectopic osteogenesis is that 
osteoblastic cells nucleate HA locally in the amniochorion, thereby attracting soluble 
fetuin-A from AF and binding it into HA plaques.   
The current theory of PPROM describes membrane rupture as an active process of 
cell proliferation (inflammation) and amniochorion activation.  However, our results 
argue that the changes occurring prior to membrane rupture in non-infected patients 
involve 1) amniotic fluid protein deprivation and 2) the generation of toxic intermediates.  
These alterations to the amniotic fluid environment lead to apoptosis of amnion cells and 
phenotypic switching of fibroblasts to osteoblasts.  Because the key components of the 
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amniochorionic extracellular matrix are not maintained, the tissue degenerates, calcifies, 
and eventually ruptures.  Based on this work, we propose an alternative model for 
understanding the mechanism of PPROM in idiopathic preterm birth (Fig. 21, next page).   
Because of the similarities between the CNP aggregation process and protein 
conformational disorders, we wanted to demonstrate proof-of-principle that the two 
processes share pathogenic similarities.  We found that mature AF-derived CNPs share 
the ability to bind Congo Red, a diazo dye that binds amyloid fibrils made of misfolded 
proteins.  Furthermore, the results of the red blood cell lysis test indicated that iCNPs 
potentially share the mechanism of pathogenesis common to all amyloid oligomers which 
is the ability to make cell membranes permeable (115).  Similar to Alzheimer’s disease 
pathology, the histological manifestation of CNP plaques in the amniochorion may be the 
end result of a long-standing pathophysiologic process.   
Reproductive tissues are programmed to age and eventually degenerate over the 
short life span of the pregnancy.  However, in pregnancies complicated by PPROM, this 
process appears to be accelerated.  Ectopic calcification is a histological end-point to this 
degenerative process with multiple mechanistic precursors including deranged mineral 
homeostasis, toxic hydroxyapatite species, nutrient deprivation, apoptosis, matrix 
degradation, and osteogenesis.   
Many questions remain regarding the role of CNP-mediated aggregation in 
membrane rupture and preterm birth.  Future directions for investigation include further 
characterization of AF-derived CNPs and their effects on the amniochorion, identifying 
triggers that prematurely initiate CNP formation, and developing therapies targeted at 
preventing CNP formation and neutralizing potentially toxic intermediates. 
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Figure 21.  Proposed mechanism of PPROM. This schematic illustration demonstrates 
the two-step process of CNP formation: (1) fetuin-A binds hydroxyapatite (HA) in 
amniotic fluid (AF), forming colloidal intermediate CNPs (iCNPs), and (2) aggregation 
of iCNPs into insoluble mature CNPs that trap and deplete AF proteins in the process of 
their assembly.  Consequences of CNP formation in AF are the result of AF protein 
depletion (2), mature CNP deposition in the amniochorion (3), and direct cytotoxicity of 
iCNPs (4).  Amnion epithelial apoptosis, ectopic osteogenesis of amnion fibroblasts, local 
prostaglandin release, and extracellular matrix degradation lead to a loss of membrane 
strength and elasticity and eventually PPROM. 
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